書籍詳細

II. 歴史

P.9 掲載の参考文献

• 1) Herzenberg, L. A., et al:Fluorescence activated cell sorting. Scientific American 234:108, 1976.
  pubmed

• 2) Van Dilla, M. A. et al:Cell microfluorometry:A method for rapid fluorescence measurement. Science 163:1213, 1969.
  pubmed

• 3) Gohde, W.:Automation of cytofluorometry by use of the impulsmicrophotometer. In:Fluorescence technique in cell biology, Eds. by Thaer, A. A. and Sernetz, M. Springer, Berlin, p.79, 1973.

• 4) Nicolini, C., et al:Physical-chemical characterization of living cells by laser flow microfluorometry. Cancer Treat. Rep.60:1819, 1976.
  pubmed

• 5) Gohde, W., et al:Simultarre impulsfluorimetrie des DNS und proteingehaltes von tumorzellen. Z. Anal. Chem. 252:328, 1970.

• 6) Fulwyler, M. J.:Electronic separation of biological cells by volume. Science 150:910, 1965.
  pubmed

• 7) Loken, M. R. et al:Analysis of cell populations with a fluorescence-activated cell sorter. Ann. N. Y. Acad. Sci. 254:163, 1975.
  pubmed

• 8) Stout, R. D. et al:The Fc receptor on thymusderived lymphocytes. I. Detection of a subpopulation of murine T lymphocytes bearing the Fc receptor. J. Exp.Med. 142:611, 1975.
  pubmed

• 9) Okumura, K. et al:Specific enrichment of the suppressor T cell bearing I-J determinants. Parallel functional and serological characterizations. J. Exp.Med. 146:1234, 1977.
  pubmed

• 10) 奥村 康・他:FACSとその応用. 感染・炎症・免疫 7:202, 1977.

• 11) Melamed, M. R. et al:Acridine orange metachromasia for characterization of Leukocytes in leukemia, lymphoma and other neoplasmas. Cancer 29:1361, 1972.

• 12) Yataganas, X., et al:Flow-microfluorometric analysis of cell killing with cytotoxic drugs. J. Histochemi. Cytochemi, 22:651, 1974.

• 13) Yataganas, X., Mitomo, Y. et al:Evaluation of a feulgentype reaction in suspension using flow microfluorimetry and a cell separation technique. Acta Cytol. 19:71, 1975.

• 14) Reynolds, O.:An experimental investigation of the circumstances which determine whether the motion of water shall be direct or sinuous, and of the law of resistance in channels. Phil. Trans. 935, 1883.

• 15) Adams, L. R., et al:Machine characterization of human leukocytes by acridine orange fluorescence. Acta Cytol. 15:289, 1971.
  pubmed

• 16) Trujillo, T. T., et al:Adaptation of the fluorescent feulgen reaction to cell in suspension for flow microfluorometry. Acta Cytol. 16:26, 1972.
  pubmed

• 17) Krishan, A.:Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188, 1975.
  pubmed

• 18) Lepecq, J. B., et al:A fluorescent complex between ethidium bromide and nucleic acids. J. Mol. Biol. 27:87, 1967.
  pubmed

• 19) Tobey, R. A., et al:Use of flow microfluorometry in detailed analysis of effects of chemical agents on cell cycle progression. Cancer Res. 32:2726, 1972.
  pubmed

• 20) Fried, J., et al:Kinetic response of human leukemic and lymphoma cells in vivo to combination chemotherapy using flow microfluorometry. Cancer Treat. Rep.60:1937, 1976.
  pubmed

• 21) 御供泰治・他:DNA瞬間自動測定装置およびその応用. 医学のあゆみ 97:863, 1976.

• 22) 太田和雄・他:DNA瞬間自動測定装置. 癌と化学療法 4:179, 1977.
  Medical*Online

• 23) Buchner, T., et al:Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside. Blut 28:299, 1974.
  pubmed

III. 定義および原理

P.23 掲載の参考文献

• 1) Melamed, M. R., et al (eds) :Flow cytometry and sorting, John Wiley and Sons. Inc., New York, 1979.

• 2) 太田和雄・他:Flow cytometry(FCM)の癌臨床への応用. 癌と化学療法 9:1140, 1982.
  Medical*Online

• 3) 野口義夫:種々のフロー・サイトメーターの現状についての調査. 電子技術総合研究所彙報 44:160, 1980.

• 4) Van Dilla, N. A., et al:Cell microfluorometry:a method for rapid fluorescence measurement. Science 163:1213, 1969.

• 5) Crissman, H. A., et al:Cell cycle analysis in 20 minutes. Science 184:1297, 1974.
  pubmed

• 6) Herzenberg, L. A., et al:Analysis and separation using the fluorescence activated cell sorter(FACS) in Handbook of Experimental Immunology. Weir, D. M. (ed.) pp.22. 1, Blackwell Scientific pub., Oxford, 1978.

• 7) Davies, K. E., et al:Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature 293:374, 1981.
  pubmed

• 8) 御供泰治・他:DNA瞬間自動測定装置およびその応用. 医学のあゆみ 97:863, 1976.

• 9) 太田和雄・他:DNA瞬間自動測定装置. 癌と化学療法 4:179, 1977.
  Medical*Online

• 10) Trujillo, T. T., et al:Adaptation of the fluorescent feulgen reaction to cells in suspension for flow microfluorometry. Acta Cytologica. 16:26, 1972.
  pubmed

• 11) Yataganas, X., et al:Evaluation of a Feulgen type reaction in suspension using flow-microfluorimetry and a cell separation technique. Acta Cytologica. 19:71, 1975.

• 12) Gohde, W., et al:Simultane Impulsfluorimetrie des DNS-und Proteingehaltes von Tumorzellen, Z. Anal. Chem. 252:328, 1970.

• 13) Buchner, T., et al:Dielmpuls cytophotometrie in der hamatologischen Cytologie. Klin. Wochenschr. 49:1090, 1971.

• 14) Herzenberg L. A., et al:Fluorescence-activated cell sorting. Sci. Am. 234:108, 1976.
  pubmed

• 15) Wheeless, L. L., et al:Slit-scan flow system for automated cytopathology. Acta Cytologica. 19:45, 1975.

• 16) Dean, P. (Lawrence Livermore 研究所, C.A., U.S.A) :私信

• 17) Salzman, G. C., et al:Cell classification by laser light scattering:Identification and separation of unstained leukocytes. Acta Cytologica. 19:374, 1975.

• 18) Moldavan, A.:Photo-electric technique for the counting of microscopical cells. Science 80:188, 1934.

• 19) Crossland-Taylor, P. J.:A device for counting small particles suspended in a fluid through a tube. Nature 171:37, 1953.

• 20) Reynolds, O.:An experimental investigation of the circumstances which determine whether the motion of water shall be direct or sinuous, and of the law of resistance in channels. Phil. Trans. 935, 1883.

• 21) Andreeff, M., et al:Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines. Blood 67:676, 1986.
  pubmed

• 22) 野口義夫:装置の構造と機能, フローサイトメトリーハンドブック, 天神美夫・他編, pp.43. サイエンスフォーラム, 東京, 1984.

IV. 試料作製法

P.36 掲載の参考文献

• 1) 辻 公美・他(分担執筆) :第5部, 免疫細胞, 免疫実験操作A:426, 日本免疫学会編, 1975.

• 2) 加納康彦・他(分担執筆) :血液細胞の分離. 臨床病理 44:55, 1981.

• 3) Krishan, A.:Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188, 1975.
  pubmed

• 4) Boyum, A.:Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21(Suppl.) :97, 1968.

• 5) Pertoft, H., et al:Separation of human monocytes on density gradients of percoll. J. Immunol. Methods, 33:221, 1980.
  pubmed

• 6) 高本 滋・他:Percoll gradientによる血液細胞分離の試み -FCM分析を含めて-. 日本血液学会雑誌 46:489, 1983.

• 7) Andreeff, M.:私信

• 8) 山中 学:血液凝固C:血小板機能, 新版, 日本血液学全書 13:415, 丸善, 東京, 1979.

• 9) Tanke, H. J., et al:Flow cytometry of human reticulocytes based on RNA fluorescence. Cytometry 1:313, 1980.

• 10) Mendelsohn, M. L., et al:The detection and sorting of rare sickle hemoglobin containing cells in normal human blood. In:Flow Cytometry IV, Laerum, O. D. et al. (eds). Universitetsforlaget, Bergen-Oslo-Trondheim, 1980.

P.44 掲載の参考文献

• 1) 杉田道夫・他:核DNA分析における新しい組織分散法の応用. 癌の臨床 28:15 30, 1982.

• 2) Hoshino, T., et al:Differencies in brain nuclear DNA as determined by flow cytometry. Neurol. Med. Chir. 17:87, 1977.
  pubmed

• 3) Hoshino, T., et al:Flow cytometry of isolated nuclei prepared from 9L rat brain tumor. Lab. Inv. 41:72, 1972.

• 4) 野村和弘:組織培養法 d) 脳. 代謝 12:1071, 1975.

• 5) Pallavicini, M. G., et al:Solid KHL tumor dispersal for flow cytometric cell kinetic analysis. Cytometry 2:54, 1981.

• 6) Pfitzer, P., et al.:Flow cytometry of human testicular tissue. Cytometry 3:116, 1982.
  pubmed

• 7) Madden, R. E., et al:Production of viable single cell suspension from solid tumors. J. Natl. Cancer Inst. 27:841, 1961.
  pubmed

• 8) Hoshino, T., et al:Clonogenicity of multiple populations of human glioma cells in vitro sorted by DNA content. Cancer 50:997, 1982.
  pubmed

• 9) Taylor, I. W.:A rapid single step staining technique for DNA analysis by flow microfluorimetry. J. Histochem. Cytochem. 28:102, 1980.

P.50 掲載の参考文献

• 1) Hedley, D. W., et al:Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31:1333, 1983.
  pubmed

• 2) Hosaka, Y., et al:Pheochromocytoma:Nuclear deoxyribonucleic acid patterns studied by now cytometry. Surgery 100:1003, 1986.

• 3) Vindelov, L. L., et al:Adetergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3:323, 1983.
  pubmed

• 4) Stephenson, R. A., et al:Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues. Cytometry 7:41, 1986.
  pubmed

P.57 掲載の参考文献

• 1) 馬場宏明・他:蛍光およびリン光 -序論-. 蛋白質 核酸 酵素 (別冊), 蛍光測定の原理と生体系への応用 (金岡祐一・他編), p5-22, 共立出版, 1974

• 2) 野口義夫:フローサイトメトリーの基礎理論. フローサイトメトリーハンドブック (天神美夫他編) p60-87, サイエンスフォーラム, 1984.

• 3) 御橋広真:螢光法で何がわかるか. 蛍光測定 生物科学への応用(木下一彦他編) p.1-44, 学会出版センター, 1982.

• 4) Waggoner, A. S.:Fluorescent probes for analysis of cell structure, function, and health by flow and imaging cytometry. in Applications of Fluorescence in the Biomedical Sciences (Taylor DL, et al. eds.) p.3-28, Alan R Liss, Inc., 1986,

• 5) Gill, J. E.:Principles of cytochemistry. in Flow cytometry and sorting. (Melamed, M. R, Mullaney, P. F. and Mendelsohn, M. L. ed.) p233-242, John Wiley and Sons Inc., 1979.

• 6) Aubin, J. E.:Autofluorescence of viable cultured mammalian cells. J. Histochem Cytochem. 27:36-43, 1979.

• 7) Weil, J. G. and Chused, T. M.:Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood 57:1099-1104, 1981.

• 8) Feller, M. J., Chen, A. S., Mont, M., et al:Patterns and intensity of autofluorescence and its relation to melanin in human epidermis and hair. Int. J. Dermatol. 18:722-730, 1979.

• 9) Trask, B., et al:Detection of DNA fluorescence in nuclei in suspension by in situ hybridization and dual beam flow cytometry. Science 230 :1404-1403, 1985.

P.73 掲載の参考文献

• 1) Hudson, B, et al:The use of ethidium bromide analogue in the dye-buoyant density procedure for the isoration of closed circular DNA:The variation of the superherix density of mitochondrial DNA. Proc. Natl. Acad. Sci. USA. 62:813, 1969.

• 2) Lepecq, J. B.:Use of ethidium bromide for separation and determination of various conformational forms and measurement of their associated enzymes. Method of Biochemical Analysis, Edited by D Glick. vol 20, Interscience Publishers, New York, 1971, pp.41-86.

• 3) Gohde, W. et al:Simultane Impulsefluorimetrie das DNA-und Proteingehaltes von Tumorzellen. Z. Aal. Chem. 251:328, 1970.

• 4) Protocol #16 Cellular DNA content, RNA removal by Ba(OH)2, Bio/Physics, System, Inc. Bald Win Place Road, Mahopac, New York, 10541.

• 5) Crissman, H. A. et al:Technique for quantitative staining of cellular DNA for flow cytometric analysis. Flow Cytometry and Sorting. Edited by Melamed MR et al:Wiley Medical Publishers, New York, pp.243-261, 1979.

• 6) Vindelov, L. L. et al:Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows. Arch. Cell Pathol. 23:227, 197

• 7) Krishan, H. A.:Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol. 66:188, 1975.

• 8) Anton, C. M. et al:The fluorescence intensity of propidium iodide bound to DNA depends on the concentration of sodium chloride. Cytometry 2:24, 1981.

• 9) Crissman, H. A. et al:Rapid staining method for analysis 0f deoxyribonucleic acid and protein in mammalian cells. J. Histochem. Cytochem. 24:64, 1976.

• 10) Kersten, W. et al:Physicochemical properties of complexes between deoxyribo-nucleic acid and antibiotics which affect ribonucleic acid synthesis(actinomycin, daunomycin, cinerubin, nogalamycin, chromomycin, mithramycin, olivomycin). Biochemistry 5:236, 1966.

• 11) Arndt-Jovin, D. J. et al:Analysis and sorting of living cells according to deoxyribonucleic acid content. Cancer 50:997, 1982.

• 12) Loewe, H. et al:Basisch substituerte 2, 6-bis-benzimidazol-derivate, eine neue chemotherapeutisch active korperklasse. Arzneim. Forsch. 24:1927, 1974.

• 13) Pallavicini, M. G. et al:Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2+M phases after irradiation of a solid tumor in vivo. Cancer Res. 39:1891, 1979.
  pubmed

• 14) Hoshino, T. et al:Clonogenicity of multiple populations of human glioma cells sorted by DNA content. Cancer 50:997, 1982
  pubmed

• 15) Latt, S. A.:Microfluometric detection of deoxyribonucleic acid in human meta-phse chromosomes. Proc. Natl. Acad. Sci. USA. 70:3395, 1973.

• 16) Latt, S. A.:Detection of DNA synthesis in interphase nuclei by fluorescence microscopy. J. Cell Biol. 62:546, 1974.
  pubmed

• 17) Perry, P. et al:New giemsa method for the differential staining of sister chromatids. Nature 251:156, 1974.
  pubmed

• 18) Kim, M. A.:Chromatid exchange and heterochromatin alteration of human chromosomes with BudR-labelling demonstrated by benzimidazol fluorochrome and Giemsa stain. Humangentik 25:179, 1974.
  pubmed

• 19) Park, C. H. et al:Superiority of DAPI over Hoechst 33342 for viable cell sorting. 7th Cell Kinetic Society Meeting, Baltimore MD, March, 1983.

P.81 掲載の参考文献

• 1) Darzynkiewicz, Z.:Acridine orange as a molecular probe in studies of nucleic acid in situ. Flow cytometry and Sorting. John Wiley, New York:285, 1979.

• 2) Darzynkiewicz, Z., et al.:New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1(2) :98, 1980.
  pubmed

• 3) Shapiro, H. M.:Flow cytometric estimation of DNA and RNA content in intact cells stained with hoechst33342 and pyronin Y. Cytometry 2(3) :143, 1981.
  pubmed

• 4) Frankfurt, O. S.:Flow cytometric analysis of double-stranded RNA content distributions. J. Histochem. Cytochem. 28(7) :663, 1980.
  pubmed

• 5) Pollack, A., et al.:Flow cytometric analysis of RNA content in different cell population using pyronin Y and methyl green. Cytometry 3(1) :28, 1982.
  pubmed

• 6) 田川 泰:制癌剤作用時のUnbalanced growthにおけるG2期蓄積とRNA量の関係. 日癌治 22(3) :590, 1987.

• 7) Nicolini, C., et al.:Mass action and acridine orange staining. Static and flow cytometry. J. Histochem. Cytochem. 27(1) :102, 1979.

• 8) Darzynkiewicz, Z., et al.:Application of pyronin Y(G) in cytochemistry of nucleic acid. Cytometry 8(2) :138, 1987.
  pubmed

• 9) Darzynkiewicz, Z., et al.:Cell cycle-specific effects of tumor necrosis factor. Cancer Res. 44:83, 1984.
  pubmed

• 10) Wallen, C. A., et al.:Comparison of two flow cytometric assays for cellular RNA-Acridine orange and propidum iodide. Cytometry 3(3) :155, 1982.

• 11) Tanke, H. J., et al.:Flow cytometry of human reticulocytes based on RNA fluorescence. Cytometry 1(5) :313, 1980.

• 12) Darzynkiewicz, Z., et al.:Cytostatic and cytotoxic properties of pyronin Y. Relation to mitochondrial localization of the dye and interaction with RNA. Cancer Res. 46:5760, 1986.
  pubmed

• 13) Pennings, A., et al.:Improved flow cytometry of cellular DNA and RNA by on-line reagent addition. Cytometry 8(3) :335, 1987.
  pubmed

P.94 掲載の参考文献

• 1) Pearse, A. G. E.:Histochemistry, Theoretical and Applied, 3rd ed., vol.2, Williams and Wilkins, Baltimore, 1186, 1972.

• 2) Zanker, H. V.:Uber den Nachweis definierter reversibler Assoziate des Acridin orange durch Absorption und Fluoreszenzmessungen in Wassriger Losung. Z. phys. Chem. 199:225, 1952.

• 3) Rigler, R. Jr.:Microfluorometric characterization of intracellular nucleic acids and nucleoproteins by acridine orange. Acta. Physiol. Scand. 67(suppl.) :267, 1966.

• 4) Darzynkiewicz, Z.:Acridine orange as a molecular probe in studies of nucleic acids in situ. Flow Cytometry and Sorting, John Wiley, New York, 285, 1979.

• 5) Darzynkiewicz, Z, et al:Conformation of RNA in situ as studied by acridine orange staining and automated cytofluorometry. Exp.Cell Res. 95:143, 1975.
  pubmed

• 6) Traganos, F., et al:Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J. Histochem. Cytochem 25:46, 1977.

• 7) Piwnicka, M., et al:RNA and DNA content of isolated cell nuclei measured by multiparameter flow cytometry. Cytometry 3:269, 1983.
  pubmed

• 8) Melamed, M. R., et al:Acridine orange as a quantitative cytochemical probe for flow cytometry. Histochemistry:The Widening Horizons, John Wiley & Sons, 237, 1981.

• 9) Darzynkiewicz, Z., et al:New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1:98, 1980.
  pubmed

• 10) Darzynkiewicz, Z., et al:Different sensitivity of DNA in situ in interphase and metaphase chromatin to heat denaturation. J. Cell Biol. 73:128, 1977.
  pubmed

• 11) Darzynkiewicz, Z, et al:Interphase and metaphase chromatin. Different stain ability of DNA with acridine orange after treatment at low pH. Exp.Cell Res. 110:201, 1977.

• 12) Narin, R. C.:Fluorescent Protein Tracing 3rd ed. Williams & Wilkins, Baltimore, 503, 1969.

• 13) Freeman, D. A., et al:Evaluation of six fluorescent protein stains for use inflow microfluorometrry. Stain Technol. 50:279, 1975.

• 14) Crissman, H. A., et al:Rapid staining methods for analysis of deoxyribonucleic acid and protein in mammalian cells. J. Histochem. Cytochem. 24:64, 1976.

• 15) Steinkamp, J. A., et al:Automated analysis of Deoxyribonucleic acid, protein and nuclear to cytoplasmic relationships in tumor cells and gynecologic specimens. J. Histochem. Cytochem. 22:616, 1974.
  pubmed

• 16) 西谷 巌・他:Flow cytometry-Computer連動による子宮癌細胞のMultiparameter解析 癌と化学療法 9:1164, 1982.

P.111 掲載の参考文献

• 1) Gratzner, H. G.:Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine:a new reagent for detection of DNA replication. Science 218:474, 1982.
  pubmed

• 2) Kohler, G., et al:Continuous cultures of fused cells secreating antibody of predefined specificity. Nature 256:495, 1975.

• 3) Dolbeare, F., et al:Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA. 80:5573, 1983.
  pubmed

• 4) Vandalaan, M., et al:Improved high-affinity monoclonal antibody to iododeoxyuridine. Cytometry 7:499, 1986.

• 5) Gonchoroff, N. J., et al:Amonoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not requrie DNA denaturation. Cytometry 6:506, 1985.

• 6) Nagashima, T., et al:Rapid detection of S-phase cells by anti-bromodeoxy uridine monoclonal antibody in 9L brain tumor cells in vitro and in situ. Acta. NeuroPathol 66:12, 1985.
  pubmed

• 7) Hoshino, T., et al:Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6:627, 1985.
  pubmed

• 8) 佐々木功典・他:モノクローナル抗BrdU抗体を利用した人癌組織の標識率測定法. 病理と臨床 3:565, 1985.

• 9) 村上知之・他:DNA-BrdUrd 同時測定のための技術的検討. フローサイトメトリー 2:39, 1985.

• 10) Moran, R., et al:Detection of 5-bromodeoxyuridine(BrdUrd) incorporation by monoclonal antibodies:Role of the DNA denaturation step.J. Histochem Cytochem 33:821, 1985.
  pubmed

• 11) Dolbeare, F., et al:Use of restriction enzymes and exonuclease III to expose BrdUrd in DNA for immunochemical assay. Cell Tissue Kinet. 20:248, 1987.

• 12) Beisker, W., et al:An improved immunocytochemical procedure for high sensitivity detection of incorporated bromodeoxyuridine. Cytometry 8:235, 1987.
  pubmed

P.121 掲載の参考文献

• 1) 杉田道夫・他:核DNA分析における新しい組織分散法の応用. 癌の臨床 28(13) :1530-1536, 1982.

• 2) 杉田道夫・他:FCM (flow cytometry) によるDNAパターンからみたcisplatin療法の効果判定. 最新医学 39(8) :1719-1721, 1984.
  Medical*Online

• 3) 天神美夫・他:癌の細胞診断. 保健の科学 26(9) :627-630, 1984.

• 4) 天神美夫・他:Flow cytometry からみた子宮頸癌の細胞像. 最新医学 40(1) :126-129, 1985.

• 5) Jones, K. H., et al:An Improved Method to Determine Cell Viability by Simultaneous Staining with Fluoresein Diacetate-Propidium Iodide. J. Histochem. Cytochem. 33(1) :77-79, 1985.

• 6) Black, L., et al:Factors Affecting the Dye Exclusion Test for Cell Viability. Exp.Cell. Res. 35:9-13, 1964.
  pubmed

• 7) Dankberg, F., et al:A Test of Granulocyte Membrane Integrity and Phagocytic Function. Cryobiology. 13:430-432. 1976.
  pubmed

• 8) Rotman, B., et al:Membrane Properties of Living Mammalian Cells as Studied by Enzymatic Hydrolysis of Fluorogenic Esters. Proc, Natl. Acad. Sci. USA. 55:134-141. 1966.
  pubmed

• 9) Celada, F., et al:A Fluorochromatic Test for Immunocytotoxicity against Tumor Cells and Leucocytes in Agarose Plates. Proc, Natl. Acad. Sci. USA. 57:630-636. 1967.
  pubmed

• 10) 岡信行・他:Fluorescein diacetate (FDA) を用いたviabilityの測定に関する基礎的研究. 関西フローサイトメトリー研究会機関誌 2:58-64, 1985.

• 11) Kvach, J. T., et al:A Fluorescent Staining Procedure for Determining the Viability of Mycobacterial cells. Int. J. Lepr. 50(2) :183-192. 1982.

• 12) Jarnagin, J. L., et al:The Use of Fluorescein Diacetate and Ethidium Bromide as a Stain for Evaluating Viability of Mycobacteria. Stain Technol. 55(4) :253-258, 1980.
  pubmed

• 13) 本間滋・他:Fluorescein Diacetate-Propidium Iodide 複合螢光染色による絨毛細胞の生死の判別法. 日産婦誌 38(11) :2089-2090, 1986.

• 14) 杉田道夫・他:治療による癌細胞の形態学的影響. Oncology & Chemotherapy 3(2) :225-232, 1987.

P.129 掲載の参考文献

• 1) Loewe, H., et al:Basisch substituerte 2, 6-bis-benzimidazol-derivate, eine neue chemotherapeutisch active korperklasse. Arzneim. Forsch. 24:1927, 1974.

• 2) Latt, S. A.:Microfluorometric detection of deoxyribonucleic acid in human metaphase chromosomes. Proc. Natl. Acad. Sci. USA. 70:3395, 1973.
  pubmed

• 3) Weisblum, B., et al:Fluorometric properties of the bis-benzimidazole derivative Hoechst 33258, a fluorescent probe specific for AT concentration in chromosomal DNA. Chromosoma 46:225, 1974.

• 4) Latt, S. A., et al:Optical studies of the interaction of 33258 Hoechst with DNA, chromatin and metaphase chromosomes. Chromosoma 52:297, 1975.
  pubmed

• 5) Bontemps, J. et al:Physico-chemical study of the complexes of "33258 Hoechst" with DNA and nucleohistone. Nucl Acids Res. 2:971, 1975.
  pubmed

• 6) Comings, D. E., :Mechanim of chromosome banding. VIII. Hoechst 33258-DNA interaction. Chromosoma 52:229, 1975.

• 7) Arndt-Jovin, D. J. et al:Analysis and sorting of living cells according to deoxyribonucleic acid content. J. Histochem Cytochem. 25:585, 1977.

• 8) Pallavicini, M. G. et al:Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumlated in G2+ M phases after irradiation of a solid tumor in vivo. Cancer Res. 39:1891, 1979.

• 9) Hoshino, T. et al:Clonogenicity of multiple populations of human glioma cells sorted by DNA content. Cancer 50:997, 1982.
  pubmed

• 10) Latt, S. A, :Detection of DNA synthesis in interphase nuclei by fluorescence microscopy. J. Cell Biol. 62:546, 1974.
  pubmed

• 11) Perry, P. et al:New Giemsa method for the differential staining of sister chromatids. Nature 251:156, 1974.
  pubmed

• 12) Kim, M. A.:Chromatid exchange and heterochromatin alteration of human chromosomes ith BUdR-wlabelling demonstrated by benzimidazol fluorochrome and Giemsa stain. Humangentik 25:179, 1974.

• 13) Park, C. H. et al: Superiority of DAPI over Hoechst 33342 for viable cell sorting. 7th Cell Kinetic Society Meeting, Baltimore MD, March, 1983.

P.137 掲載の参考文献

• 1) Fulwyler, M. J.:Standards for flow cytometry. In:Flow cytometry and sorting(M. R. Melamed, et al. eds.) pp.351, John Wiley and Sons. Inc., New York. 1979.

• 2) Herzenberg, L. A., et al:Analysis and separation using the fluorescence activated cell sorter (FACS). In:Handbook of experimental immunology, (Weir, D. M. ed.) pp.221, Blackwell Scientific Publications, Oxford, 1978.

• 3) Dow Diagnostics, P. O. Box 68511, Indianapolis, IN 46268. U.S.A.

• 4) Polysciences, Inc., Paul Valley Industrial Park, Warrington, PA 18976, U.S.A.

• 5) Duke Standards Co., 445 Sherman Ave., Palo Alto, CA 94306, U.S.A.

• 6) Coulter Electronics, Inc., 590 W. 20th Street Hialeah, FL 33010, U.S.A.

• 7) Cram, L. S., et al:Flow microfluorometric DNA content measurements of tissue culture cells and peripheral lymphocytes. Human Genet. 37:201, 1977.
  pubmed

• 8) Schackney, S. E., et al:The T-lymphocytes as a diploid reference standard for flow cytometry, Cancer Res. 39:4418, 1979.

• 9) Barlogie, B., et al:Flow cytometric analysis of DNA content for ploidy determination in human solid tumors. J. Histochem, Cytochem. 27:505, 1979.
  pubmed

• 10) Noguchi, P. D., et al:The use of chicken erythrocyte nuclei as a biological standard for flow microfluorometry. J. Histochem Cytochem. 26:761, 1978.
  pubmed

• 11) Tannenbaum, E., et al:Measurement of cellular DNA mass by flow microfluorometry with use of a biological internal standard. J. Histochem. Cytochem. 26:145, 1978.

• 12) Vindelov, L. L., et al:Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 3:328, 1983.
  pubmed

• 13) 高本 滋・他:FCMによる腫瘍マーカーとしての異数倍数体の検索, -第一報, 標準試料について-. 日血会誌 47:308, 1984.

• 14) 高本 滋:腫瘍マーカーとしてのDNA aneuploidyの検索. 関西フローサイトメトリー 6:3, 1987.

• 15) Iversen, O. E., et al:Trout and salmon erythrocytes and human leukocytes as internal standards for ploidy control in flow cytometry. Cytometry 8:190, 1987.
  pubmed

• 16) Particle Information Service, 600 South Springer Road, Los Altos, CA 94022, U.S.A.

• 17) Andreeff, M., et al:Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55:282, 1980.
  pubmed

• 18) Barlogie, B., et al:Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma. Cancer Res. 37:4400, 1977.
  pubmed

• 19) Vindelov, L. L., et al:Clonal heterogeneity of small cell anaplastic carcinoma of the lung demonstrated by flow cytometric DNA analysis. Cancer Res. 40:4295, 1980.
  pubmed

• 20) Hoshino, T., et al:The distribution of nuclear DNA from human brain tumor cells. J. Neurosurg. 49:13, 1978.

• 21) Hiddemann, W., et al:Convention on nomenclature for DNA flow cytometry. Cytometry 5:445, 1984.

VI. セル・ソーティング

P.155 掲載の参考文献

• 1) Sweet, R. G.:High frequency recording with electrostatically deflected ink jet. Rev. Sci. Inst. 36:131, 1965.

• 2) Sweet, R. G.:Flow sorters for biologic cells:in Melamed, M. R., Mullaney, P. F., Mendelsohn, M. L. (ed.) "Flow Cytometry and Sorting" Wiley&Son, New York, pp.177-189, 1979.

VII. 応用

P.171 掲載の参考文献

• 1) Bernengo MG, et al:T cell subsets in melanoma patients evaluated by anti-T-cell monocloal antibodies. Thymus 5:223, 1983. 1983.
  pubmed

• 2) Blanca I, et al:Immunolgy of human gastric cancer. A preliminary report. Cancer 49:1810, 1982.

• 3) Bolton PM, et al:Cellular immunity in cancer:Comparison of delayed hypersensitivity skin tests in three common cancers. Brit. Med. J. 3:18, 1975.
  pubmed

• 4) Karavodin LM, et al:T lymphocyte subsets in patients with malignant melan-oma. Cancer. Immunol. Immunother. 11:251, 1981.

• 5) 小島 治・他:胃癌患者における末梢リンパ球数測定の臨床的意義, 細胞性免疫能および, 胃癌の進行度, 予後との相関. J. Jap.Soc. Cancer. Ther. 15:828, 1980.

• 6) Lala PK, et al:An analysis of T lymphocyte subsets in tumor-transplanted mice on the basis of Ly antigenic markers and functions. Immunology 47:663, 1982.
  pubmed

• 7) Ledbetter JA, et al:Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations inmouse and man. J. Exp, Med. 153:310, 1981.

• 8) McCluskey DR, et al:T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease. Brit. J. Cancer 47:307, 1983
  pubmed

• 9) Orita K, et al:Preoperative cell-mediated immune status of gastric cancer patients. Cancer 38:2343, 1976.
  pubmed

• 10) Reinherz EL, et al:Regulation of the immune response-inducer and suppressor T lymphocyte subsets in human being. N. Eng. J. Med. 303:370, 1980.

• 11) Stahl RE, et al:Immunologic abnormalities in homosexual men. Relationship to Kaposis sarcoma. Am. J. Med. 73:171, 1982.
  pubmed

• 12) 渡辺 卓・他:胃癌患者における末梢血リンパ球サブセットの解析. 日本癌学会総会記事:147, 1983,

P.186 掲載の参考文献

• 1) 中原一彦:表面マーカーからみた病像と予後. Modern Physician 7:263, 1987.

• 2) Landy, A., et al:Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J. Immunol. 131:2757, 1983.

• 3) Clement, L. T., et al:Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J. Immunol. 133:2461, 1984.
  pubmed

• 4) Clement, L. T., et al:Characterization of human lymphocyte subpopulations:Alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu2+ suppressor cells. J. Clin. Immunol. 4:395, 1984.

• 5) Gatenby, P. A., et al:Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J. Immunol. 129:1997, 1982.

• 6) Damle, N K., et al:Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigenpulsed accessory cells:phenotypic definition of suppressor-inducer and suppressor-effector cells. J. Immunol. 132:644, 1984.

• 7) Morimoto, C., et al:The isolation and characterization of the human suppressor inducer T cell subset. J. Immunol. 134:1508, 1985.
  pubmed

• 8) Evans, R. L., et al:Peripheral human T cells sensitized in mixed Ieukocyte culture synthesize and express Ia-like antigens. J. Exp.Med. 148:1440, 1978.

• 9) Yu, D. T. Y., et al:Peripheral blood Ia-positive T cells. J. Exp.Med. 151:91, 1980.

• 10) Abo, T., et al:Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J. Exp.Med. 157:273, 1983.

• 11) 安保 徹:モノクローナル抗体を用いたヒトNK細胞の解析. 最新医学 39:51, 1984.
  Medical*Online

P.206 掲載の参考文献

• 1) 江口勝美・他:SLE患者における自己リンパ球混合培養反応とこの反応により誘導される細胞傷害性Tリンパ球. 臨床免疫 15:77, 1983.

• 2) Morimoto, C., et al.:Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J. Clin. Invest. 66:1171, 1980.
  pubmed

• 3) Smolen, J. S., et al.:Systemic lupus erythematosus:delineation of subpopulations by clinical, serologic, and T cell subset analysis. American J. Medical Sciences. 289:139, 1985.

• 4) Morimoto, C., et al.:Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J. Clin. Invest. 73:689, 1984.

• 5) 佐藤和人・他:SLE患者リンパ球における表面抗原の解析 -二重螢光染色法を用いたFACSによる検討-. 医学のあゆみ 138:205, 1986.
  Medical*Online

• 6) 高井修・他:SLE-B細胞におけるDR抗原表現の異常. 臨床免疫19(Suppl. 11), 227, 1987.

• 7) 江口勝美・他:RA患者の免疫学検討(第4報)-RA患者滑液中のT細胞サブセットについての検討-. 九州リウマチ 6:144, 1987.

• 8) Goto, M., et al.:T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids:Arthritis Rheum. 30:737, 1987.

• 9) Emery, P., et al.:Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum. 30:849, 1987.
  pubmed

• 10) 下村周子・他:RA患者末梢血及び関節液中の単球マクロファージにおけるla抗原の表現に関する検討. 第29回日本リウマチ学会総会(福岡), 1985年5月9, 10日.

• 11) Firestein, G. S., et al.:Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. I. a cytofluorographic study of monocyte differentiation antigens and class II antigens and their regulation by γ-interferon. Arthrits Rheum. 30:857, 1987.

• 12) 西岡久寿樹・他:慢性関節リウマチの病態-関節内免疫応答の解析を中心に-. Medical Immunology. 13:265, 1987.

• 13) 沢井高志・他:慢性関節リウマチの病理, 病態-最近の進歩から-. Medical Immunology 13:747, 1987.

• 14) Masuyama, J., et al.:Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. J. Clin. Invest. 77:1596, 1986.
  pubmed

• 15) 江口勝美・他:自己抗体の多様性と臨床的意義-臓器特異的自己免疫疾患-. Medical Immunology. 14:767, 1987.

• 16) Ishikawa, N., et al.:The reduction in suppressor-inducer T cell subset and increase in helper T cell subset in thyroid tissues from patients with Gravesdisease. J. Clin. Endocrinol. Metab. 65:17, 1987.

• 17) 江口勝美・他:疾患と免疫-免疫学は疾患理解にどこまで寄与したか-甲状腺疾患. Medical Immunology. 13:771, 1987.

• 18) Ludgate, M. E., et al.:Analysis of T cell subsets in Gravesdisease:alternations associated with carbimazole. British Medical J. 288:526, 1984.

• 19) Chan, J. Y. C., et al.:Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid disease:analysis by dual laser flow microfluorocytometry. J. Clin. Endocrinol. Metab. 62:403, 1986.

• 20) Hafler, D. A., et al.:Antigen reactive memory T cells are defined by Tal. J. Immunol. 137:414, 1986.

• 21) Margolick, J. B., et al.:Immunohistochemical characterization of intrathyroid lymphocytes in Gravesdisease:interstitial and intraepithelial populations. Amer. J. Med. 76:815, 1984.

• 22) Warford, A., et al.:Characterization of lymphoid cells in thyroid of patients with Gravesdisease. Clin. Exp.Immunol. 57:626, 1984.

• 23) Bene, M. C., et al.:Graves' disease:in situ localization of lymphoid T cell subpopulations. Clin. Exp. Immunol. 52:311, 1983.
  pubmed

• 24) Jansson, R., et al.:Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goiter. Clin Exp Immunol. 58:264, 1984.

• 25) Ueki, Y., et al.:Dysfunction of suppressor T cells in thyroid glands from patients with Gravesdisease. J. Clin. Endocrinol. Metab. 65:922, 1987.

• 26) Tezuka, H., et al.:Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Gravesdisease. J. Clin. Endocrinol. Metab. 66:1988. (in press)

• 27) Selmaj, K., et al.:Multiple sclerosis:increased expression of interleukin-2receptors on lymphocytes. Neurology 36:1392, 1986.
  pubmed

• 28) 中尾英人・他:多発性硬化症の臨床経過に伴う活性化T細胞, Tal陽性細胞の変動とその意義. 医学のあゆみ 143:107, 1987.

• 29) Matsunaga, M. et al.:Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Gravesdisease. J. Clin. Endocrinol. Metab. 62:723, 1986.

• 30) 江口勝美・他:バセドウ病における甲状腺濾胞細胞のクラス II MHC抗原の発現意義について. ホルモンと臨床 35:57, 1987.

• 31) 江口勝美・他:Graves病における免疫学的検討-特に甲状腺組織内における細胞間相互作用について. 臨床免疫 19(Suppl. 11) :265, 1987.

P.216 掲載の参考文献

• 1) Miller, i. f. a. p., Mitchell G. F.:Thymus and Antigen Reactive Cells. In A-ntigen Sensitive Cells. Transpl. Rev. Vol 1 Munnksgaad. Copenhagen, 1969.

• 2) EPSTEIN BARR 1964, Cultivation in vitro of human lymphoblasts from Burkitts malignant lymphoma. Lancet 1:252-253.
  pubmed

• 3) 玉川重徳・他:第61回日本感染症学会, 報告 1987. 4. 2-3.

• 4) McDougal, J. S., et al:Binding of HTLV-111/LAV to T 4 t cells by a complex of the 110 K viral protein and the t4 molecul. Science 231:382, 1986.

• 5) Dalgleish, A. G., et al:The CD4 antigen in an essential component of the receptor for the AIDS retrovirus. Nature 312:763, 1984.

• 6) 玉川重徳・他:第一回AIDS研究会発表, 1987. 12. 21-22. 京都にて.

• 7) 森 茂郎・他:第一回AIDS研究会発表, 1987. 12. 21-22. 京都にて.

P.224 掲載の参考文献

• 1) Rosenberg, S. A., Lotze, L. M., et al:Observation on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485, 1985.

• 2) Grim, E. A., Mazunder, A., et al:Lymphokine activated killer cell phenomenon II :J. Exp.Med. 157:884, 1983.

• 3) Itho, K., Tilden, K. B. and Black, C. H.:Lysis of human solid tumor cell by lymphokine activated killer cells. J. Immunol. 136:3910, 1986.

• 4) 蟹沢祐司, 高後裕, 笹川 裕・他:cell sorterを用いて分取したIL-2 activated killer細胞の多様性. 医学のあゆみ 140(3) :165, 1987.

• 5) 古江 尚:インターフェロンの投与法と副作用-生体内動態からみて. 癌と化学療法 11:186, 1984.
  Medical*Online

• 6) David, W.:Regulation of susceptibility to natural killer cell's cytotoxicity and regulation of HLA synthesis, differing efficucies of alpha, beta and gamma interferons. J. Interferon Res. 2(3) :329, 1982.

• 7) Pace, J. L, Russell. S. W., Torres, B. A. et al:Recombinant mouse i-interferon induces the priming step in macrophage activation for tumor cell killing. J. Jmmunol. 130:2011, 1983.
  pubmed

• 8) 小川一誠, 高久史麿・他:遺伝子組換えインターフェロンγのphase I study. 癌と化学療法 14(2) :446, 1987.

• 9) 原口惣一, 小出幸夫・他:組換えインターフェロンα-2bによるin vitro抗腫瘍活性の多面的検討. 癌と化学療法 13(11) :3326, 1986.

• 10) Becker, S.:Influence of Interferon on human monocyte to macrophage develop-ment. Cellular Immunology 84:145, 1984.
  pubmed

• 11) Uchida, A. and Mickshe, M.:In vivo augmentation of natural killer activity by OK-432. Intern. J. Immunopharm. 3:365, 1981.

• 12) Uchida, A. and Mickshe, M.:Intrapleural administration of OK-432 in cancer patients. Activation of NK cells and reduction of suppressor cell. Intern. J. Cancer 31:1, 1983.

• 13) 仁尾義則, 土谷利晴・他:胃癌における末梢血, 脾静脈血, 腸間膜リンパ節のリンパ球subsetとNK活性およびOK-432経口投与によるそれらの変動. 消化器と免疫 15:29, 1985.

• 14) 松永謙一, 森田伊津子・他::X5563担癌マウスにおける免疫能の変動とPSKの効果. 癌と化学療法 13(2) :3453, 1986.

• 15) 上野芳経, 高後 裕・他:PSK primingによるIL-2 activated killer 細胞活性増強効果. 消化器と免疫 19:72, 1987.

• 16) 守安文明, 合地 明・他:免疫賦活剤クレスチンの腫瘍内投与による腫瘍内及び末梢血中リンパ球サブセットに及ぼす効果:第14回国際化学療法学会記事. 1985.

• 17) 加藤治樹, 佐野 統・他:癌性腹膜炎に対するOK-432と凍結血漿同時腹腔内投与による癌細胞付着分子の変化. 第14回国際癌学会記事 1986.

• 18) Basham, T. T. and Merigan, T. C.:Recombinant interferon-γ increase HLA-DR synthesis and expression. J. Immunol. 130:1429, 1983.

• 19) 螺良英郎, 塚越茂・他:BRM 医薬ジャーナル社 48, 197.

P.248 掲載の参考文献

• 1) Van Dilla, M. A., et al:Cell microfluorometry:a method for rapid fluorescence measurement. Science(Wash. D. C.) 163:1213, 1968.

• 2) Crissman, H. A., et al:Cell cycle analysis in 20 minutes. Science(Wash. D. C.), 184:1297, 1974.

• 3) 太田和雄・他:DNA瞬間自動測定装置. 癌と化学療法 4:179, 1977.
  Medical*Online

• 4) Herzenberg, L. A., et al:Fluorescence-activated cell sorting. Sci. Am. 234:108, 1976.
  pubmed

• 5) Herzenberg, L. A., et al:Analysis and separation using the fluorescence activated cell sorter(FACS). In Weir, D. M. (ed.). Handbook of Experimental Immunology. pp.22. 1. Blackwell Scientific Pub., Oxford, 1978.

• 6) Kohler, G., et al:Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495, 1975.
  pubmed

• 7) Ueda, R., et al:Serological analysis of cell surface antigens of null cell acute lymphoblastic leukemia by mouse monoclonal antibodies. Proc. Natl. Acad. Sci. 79:4386, 1982.

• 8) Levy, R., et al:A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc. Natl. Acad. Sci. 76:6552, 1979.

• 9) Ritz, J., et al:A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature 283:583, 1980.

• 10) Kersey, J. H., et al:p.24:A human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J. Exp.Med. 153:726, 1981.
  pubmed

• 11) Deng, C-T., et al:Monoclonal antibody specific for human T acute lymphoblastic leukemia. Lancet 1:10, 1982.

• 12) Koprowski, H., et al:Study of antibodies against human melanoma produced by somatic cell hybrids. Proc. Natl. Acad. Sci. 75:3405, 1978.
  pubmed

• 13) Dippold, W. G., et al:Cell surface antigens of human malignant melanoma:Definition of six antigenic systems with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. 77:6114, 1980.
  pubmed

• 14) Imai, K., et al:Characterization of monoclonal antibodies to human melanoma-associated antigens. J. Natl. Cancer Inst. 66:489, 1981.
  pubmed

• 15) Herlyn, M., et al:Colorectal carcinoma-specific antigen:Detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. 76:1438, 1979.
  pubmed

• 16) Sears, H. F., et al:Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet 1:762, 1982.
  pubmed

• 17) Miller, R. A., et al:In vivo effects of murine hybridoma monoclonal antibody in a patient with T cell leukemia. Blood 58:78, 1981.

• 18) Ritz, J., et al:Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59:1, 1982
  pubmed

• 19) 高本 滋・他:Flow cytometry(FCM) によるモノクローナル抗体を用いた白血病の細胞表面抗原の解析およびその応用. 癌と化学療法 9:1191, 1982.

• 20) Kamoun, M., et al:A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. J. Immunol. 127:987, 1981.

• 21) Ritz, J., et al:Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro. J. Immunol. 125:1506, 1980.
  pubmed

• 22) Benett, J. M., et al:Proposals for the classification of the acute leukemias. Brit. J. Haemat. 33:451, 1976.

• 23) Greaves, M. F., et al:Antisera to acute lymphoblastic leukemia cells. Clin. Immunol. Immunopathol. 4:67, 1975.
  pubmed

• 24) 上田龍三・他:白血療細胞の解析, -特にNull-ALL 関連抗原を中心にして-. 臨床免疫 14〔Suppl, b〕:182, 1982.

• 25) 上田龍三:急性白血病亜分類とモノクローナル抗体, 癌と化学療法 10:559, 1983.
  Medical*Online

• 26) Kennet, R. H., et al:Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science 203:1120, 1979.

• 27) Jones, N. H., et al:Characteristics and distribution of a 24000 dalton antigen defined by a monoclonal antibody generated to common acute lymphoblastic leukemia cells. In:Advances in Comparative Leukemia Research 1981, Yohn, D. S., et al(eds) :pp.517, Elsevier North-Holland, Amsterdam, 1982.

• 28) Namikawa, R., et al:Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promotor. Leukemia Res. 7:375, 1983.

• 29) 並川玲子・他:モノクローナル抗体の白血病診断への応用-顆粒球-単球系を中心として-. 臨床科学 19:268, 1983.

• 30) 高本 滋・他:Flow cytometry(FCM) による, 顆粒球-単球系細胞に反応を示すモノクローナル抗体の血清学解析. 第42回日本癌学会記事. 154, 1983.

• 31) Uchiyama, T., et al:A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. J. Immunol. 126:1393, 1981.

• 32) Hinuma, Y., et al:Adult T cell leukemia:Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. 78:6476, 1981.

• 33) Hattori, T., et al:Surface phenotype of Japanese adult T cell leukemia cells characterized by monoclonal antibodies. Blood 58:645, 1981.
  pubmed

• 34) 淀井清司・他:IL-2レセブター, -成人T細胞白血病(ATL)における異常発現-. 医学のあゆみ 126 :387, 1983.

• 35) Tsudo, M., et al:Failure of regulation of Tac antigen/TCGF receptor on adult T cells leukemia cells by anti-Tac monoclonal antibody. Blood 1983(in press)

• 36) 西田敬子・他:成人T細胞白血病(ATL)関連抗原に対するモノクローナル抗体の製作とその解析. 第42回日本癌学会総会記事. 100, 1983.

• 37) Cossman, J., et al:Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J. Exp.Med. 157:1064, 1983.
  pubmed

• 38) Metzgar, R. S., et al:Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J. Exp.Med. 154:1249, 1981.
  pubmed

• 39) Korsmeyer, S. J., et al:Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc. Natl. Acad. Sci. 78:7096, 1981.

• 40) Brown. S., et al:Immunoglobulin secretion by mouse X human hybridomas:an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma. J. Immunol. 126:1037, 1980.

P.262 掲載の参考文献

• 1) Foon, K. A., et al:Immunologic classification of leukemia and lymphoma. Blood 68:1, 1986.
  pubmed

• 2) 湊啓輔・他:造血器腫瘍と細胞膜マーカー. 代謝 24(癌'87) :167, 1987.

• 3) Bernard, A., et al(ed.) :"Leucocyte Typing." Springer-Verlag, Berlin. 1984.

• 4) Reinherz, E. L., et al(ed.) :"Leukocyte Typing II." Springer-Verlag, New York. 1986.

• 5) McMichael, A. J, et al(ed.) "Leukocyte Typing III."Oxford University Press, Oxford, 1987.

• 6) 野々山恵章・他:FAB分類上L2に属するが骨髄単球系の表面抗原を有した急性白血病2症例の臨床的検討. 臨床血液 27:860, 1986

• 7) Takase, K., et al:Cytoplasmic CD3 antigen and T cell receptor gene rearrangement in surface CD3 negative T cell malignancy. Jpn. J. Clin. Oncol. 17:237, 1987.

• 8) 大川洋二・他:分化抗原による白血病細胞の分類と分化抗原の抗原特異性の検討. 臨床血液 28:1, 1987.

• 9) 高瀬浩造:FCM(flow cytometry)によるリンパ球表面抗原分析の実際. 臨床免疫 19 (Suppl. 12) :19, 1987.

• 10) 高瀬浩造・他:モノクローナル抗体による細胞表面抗原検出における非特異反応の成因とその除去に関する研究. 日本臨床免疫学会会誌 8:184, 1985.

• 11) 塩崎宏子・他:A case of acute biphenotypic leukemia. 臨床血液 28:743, 1987.

P.275 掲載の参考文献

• 1) Shimoyama, M.:Monoclonal antibodies and immunodiagnosis of leukemia/ lymphoma. Acta Haematol. Jpn. 48:1711-1730, 1985.

• 2) Blue, M-L., et al.:Lectin activation induces T4, T8 coexpression on peripheral blood T-cells. Leucocyte typing II, 1:89-99, 1986.

• 3) Morimoto, C., et al.:The isolation and characterization of the human suppressor inducer T-cell subset. J. Immunol. 134:1508, 1985.
  pubmed

• 4) Morimoto, C., et al.:The isolation and chracterization of the human helper inducer T-cell subset. J. Immunol. 134:3762, 1985.

• 5) Shimoyama, M., et el.:Non-T cell lymphoma and chronic lymphocytic leukemia:Immunologic and clinicopathologic study. Jpn. J. Clin. Oncol. 10:241-254, 1980.

• 6) Shimoyama, M.:Cellular origin, differentiation and classification of leukemia and lymphoma cells based on surface marker analysis. Acta Haematol. Jpn. 42:897-917, 1979.

• 7) Shimoyama, M., et al.:Monoclonal antibody studies in B(non-T)-cell malignancies. Jpn. J. Clin. Oncol. 13:477-488, 1983.

• 8) Shimoyama, M., et al.:Cellular origin of T-cell malignancies. In"Adult T-cell leukemia and related disease, Gann Monograph on Cancer Research, No. 28. Hanaoka, M., Takatsuki K. Shimoyama. M. (eds). P. 23-35, Japan Scientic Societies Press, 1982.

• 9) Reynolds, C. W. and Foon, K. A.:Tγ-lymphoproliferative disease and related disorders in humans and experimental animals:A review of the clinical, cellular, and functional characteristics. Blood 64:1146-1158, 1984.

• 10) Kadin, M. E., et al.:Erythrophagocytic T-lymphoma. A clinical pathologicentity resembling malignant histiocytosis. N. Engl. J. Med. 304:648-653, 1981.

• 11) Reinherz, E. L., et al.:Discrete stages of intrathymic differentiation:Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. USA. 77:1588, 1980.
  pubmed

• 12) Lanier, L. L., et al.:Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis:Implications for differentiation. J. Immunol. 137:2501-2507, 1986.
  pubmed

P.286 掲載の参考文献

• 1) 橋本好一, 中木陽子, 雨宮洋一:フローサイトメトリーによる赤血球抗原, 抗体の測定法. Immunohaematology 8:458, 1986.

• 2) Langlois, R. G., Bigbee, W. L. and Jensen, R. H.:Flow cytometric characterization of normal and variant cell with monoclonal antibodies specific for glycophorin A. J. Immunol. 134:4009, 1985.
  pubmed

• 3) Oien, L., Nancy, S. and Carratty, G.:Zygosity determination using flow cytometry-A superior method. Transfusion 25:474, 1985.

• 4) 田村 真, 高橋博之, 中山陽子・葛西森夫:輸血前検査におけるフローサイトメトリー赤血球抗原抗体反応の検出. 臨床病理 33:1386, 1985.

• 5) Valinsky, J. E., Marsh, W. L. and Bianco, C.:Flow cytometric procedure for estimation of transfused erythrocyte survival in vivo. Transfusion 25:478, 1985.

• 6) van Bockstaele, D. R., Berneman, Z. N., Muylle, L., Cole-Dergent, J. and Peetermans, M. E.:Flow cytometric analysis of erythrocytic D antigen density profile. Vox. Sang. 51:40, 1986.

• 7) de Bruin, H. G., de Leur-Ebeling, I. and Aaiji, C.:Quantitative determination of the number of FITC-molecules bound per cell in immunofluorescence flow cytometry. Vox. Sang. 45:373, 1983.

P.297 掲載の参考文献

• 1) 東 克己, 橋本 互:モノクローナル抗体による細胞表面マーカー分析上の問題点-特に検体の取扱いについて-. 臨床免疫 19(Suppl 11) :42, 1987.

• 2) 高瀬浩造:Two color flow cytometryの実際と問題点. 臨床免疫 18:253, 1986.

• 3) George, J. N., et al:Platelet membrane glycoproteins. Plenum publishing corporation, 1985, p.51.

• 4) Montgomery, R. R., et al:Diagnosis of Bernard-Soulier syndrome and Glanzmam's thrombasthenia with a monoclonal assay on whole blood. J. Clin. Invest. 71:385, 1983.

• 5) Bennet, J. M., et al:Criteria for the diagnosis of acute leukemia of megakaryocyte lineage(M7);A report of the French-American-British Cooperative Group. Anal. Int. Med. 103:460, 1985.

• 6) 岩永隆行:血小板輸血. 成分輸血の進歩と実際. 丸善, 東京, 1985, p.41.

• 7) Shibata, Y., et al:Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang., 41:25, 1981.
  pubmed

• 8) Von dem Borne, A. E. G., et al:A simple immunofluorescence test for the detection of platelet antibodies. Br. J. Haematol. 39:195, 1978.

• 9) 椿 和央・他:FITC標識による抗血小板抗体の検出および血小板交差試験への応用. 関西フローサイトメトリー研究会機関誌 2:20, 1985.

• 10) Werheught, F. W. A., et al:The detection of granulocyte alloantibodies with an indirect immuno fluorescence test. Br. J. Haematol. 36:533, 1977.

• 11) Mclean, I. W. and Nakane, P. K.:Periodate Lysine-Paraform-aldehyde fixative:A new fixative for immunoelectron microscopy. J. Histochem. 22:1077, 1974.

• 12) 椿 和央, 堀内 篤:Flow cytometryによる抗血小板抗体の測定. 臨床免疫 19(Suppl. 11) :59, 1987.

• 13) 椿 和央:骨髄抑制出血傾向への対策. Medicina 25:94, 1988.

• 14) Stux, S., et al:Platelet HLA typing and cross-matching by a direct microcytotoxic assay. Vox Sang. 39:15, 1980.

• 15) Szatkowski, N. S. and Aster, R. H.:HLA-antigen of platelets IV. Influence of "Private" HLA-B locus specifities on expression of Bw4 and Bw6 on human platelets. Tissue Antigen 15:361, 1981.

• 16) Braud, A., et al:Platelet transfusion therapy. Optimal donor selection with combination of lymphocytotoxicity and platelet fluorescence test. Blood 51:781, 1978.

• 17) 荒木千枝子・他:血小板輸血の交差適合試験における抗ヒトグロブリン-リンパ球細胞毒試験の有用性について. 日輸会誌 31:71, 1985.

P.309 掲載の参考文献

• 1) Shapiro, H. M.:Multistation multiparameter flow cytometry:A critical review and rationale. Cytometry 3:227-243, 1983.
  pubmed

• 2) Gratzner, H. G.:Monoclonal antibody to 5-bromo and 5-iododeoxyuridine:A new reagent for detection of DNA replication. Science 218:474-475, 1982.
  pubmed

• 3) Dolbeare, F., Gratzner, H., Pallavicini, M. G. and Gray, J. W.:Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA. 80:5573-5577, 1983.
  pubmed

• 4) Vanderlaan, M., Watkins, B., Thomas, C., Dolbeare, F. and Stanker, L.:Improved high-affinity monoclonal antibody to iododexyuridine. Cytometry 7:499-507, 1986.

• 5) Oud, P. S., Henderik, J. B. J., Beck, H. L. M., Veldhuizen, J. A. M., Vooijs, G. P., Herman, C. J. and Ramaekers, F. C. S.:Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labeling for cytokeratin using a monoclonal antibody. Cytometry 6:159-164, 1985.

• 6) Bijman, J. Th., Wagener, D. J. Th., Wessels, J. M. C., van den Brock, P. and Ramaekers, F. C. S.:Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry. Cytometry 7:76-81, 1986.

• 7) Hendy-Ibbs, P., Cox, H., Evan, G. I. and Watson, J. V.:Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Br. J. Cancer 55:275-282, 1987.

• 8) Takahashi, M.:Cytochemical approach to isoenzyme related to malignancy. In:Color Atras of Cancer Cytology, Takahashi, M. (ed.) Igakushoin, Tokyo, 1981, pp.131.

• 9) Oud, P. S., Zahniser, D. J., Haag, D. J., van Boekel, M. C. G., Hermkens, H. G., Herman, C. J. and Vooijs, G. P.:A new disaggregation device for cytology specimens. Cytometry 5:509-514, 1984.

• 10) Brattain, M. G.:Tissue disaggregation. In:Flow Cytometry and Sorting, Melamed, M. R., Mullaney, P. F., Mendelsohn, M. L(eds.) John Wiley & Sons, New York, pp.193, 1979.

• 11) 水野重孝, 磯部 宏, 伊藤正美, 井上勝一, 宮本 宏, 川上義和:Flow cytometryのための癌組織細胞分散法の検討-ペプシン消化法について-. 日臨細胞誌 26:621-627, 1987.

• 12) Ensley, J. F., Maricorowski, Z., Pietraszkiewicz, H., Klemic, G., Kukuruga, M., Saparereto, S., Corbett, T., and Crissman, J.:Solid tumor preparation for flow cytometry using a standard murine model. Cytometry 8:479-487, 1987.

• 13) Marti, G. E., Schuette, W., Margruder, L. and Gralnic, H. R.:Amethod toaverage immunofluorescent histograms. Cytometry 7:450-452, 1986.

• 14) Jacobberger, J. W., Fogleman, D. and Lehman, J. M.:Analysis of intracellular antigens by fow cytometry. Cytometry 7:356-364, 1986.

P.324 掲載の参考文献

• 1) Hayflick, L. and Moorhead, P. S.:The serial cultivation of human diploid cell strains. Exp.Cell Res. 25:585-621, 1961.
  pubmed

• 2) Hayflick, L.:The limited in vitro lifetime of human diploid cell strains. Exp.Cell Res, 37:614-636, 1965.
  pubmed

• 3) Hayflick, L.:Recent advances in the cell biology of aging. Mech. Age. Develop.14:59-79, 1980.

• 4) Stanulis-Praeger, B. M.:Cellular senescence revisited:a review. Mech. Age. Develop.38:1-48, 1987.

• 5) 加治和彦:動物線維芽細胞の老化. 組織培養 10:338-344, 1984.

• 6) Matsumura, T., Zerrudo, Z. and Hayflick, L.:Senescent human diploid cells in culture:Survival, DNA synthesis and morphology. J. Geront. 34:328-334, 1979.
  pubmed

• 7) Kaji, K. and Matsuo, M.:Aging of chick embryo fibroblasts in vitro. III. Polyploid cell accumulation. Exp.Cell Res. 119:231-236, 1979.
  pubmed

• 8) Kaji, K. and Matsuo, M.:Aging of chick embryo fibroblasts in vitro. V. Time course studies on polyploid nucleus accumulation. Exp.Cell Res. 131:410-412, 1981.
  pubmed

• 9) Yanishevsky, R. and Carrano, A. V.:Prematurely condensed chromosomes of dividing and non-dividing cells in aging human cell cultures. Exp.Cell Res. 90:169-174, 1975.
  pubmed

• 10) Kaji, K. and Matsuo, M.:Aging of chick embryo fibroblasts in vitro-M. Saturation density and population doubling rate. Exp.Geront. 13:439-445, 1978.

• 11) Matsuo, M. and Kaji, K.:Aging of chick embryo fibroblast in vitro-M. Different aging patterns of population doubling rate and polyploidization. Exp.Geront. 16:25-30, 1981.

• 12) Matsuo, M., Kaji, K., Utakoji, T. and Hosoda, K.:Ploidy of human embryonic fibroblasts during in vitro aging. 37:33-37, 1982.
  pubmed

• 13) Thompson, K. V. A. and Holliday, R.:Chromosome changes during the in vitro ageing of MRC-5 human fibroblasts. Exp.Cell Res. 96:1-6, 1975.
  pubmed

• 14) Mitsui, Y. and Schneider, E. L.:Increased nuclear sizes in senescent human diploid fibroblasts cultures. Exp.Cell Res. 100:147-152,
  pubmed

• 15) Lee, S. -C., Bemiller, P. M., Bemiller, J. N. and Pappelis, T. J.:Nucear area changes in senescing human diploid fibroblasts. Mech. Age. Develop.7:417-424, 1978.

• 16) Miller, R. C., Nichols, W. W., Pottash, J. and Aronson, M. M.:In vitro aging:Cytogenetic comparion of diploid human fibroblast and epithelioid cell lines. Exp.Cell Res. 110:63-73, 1977.

• 17) Nichols, W. W., Buynak, E. B., Bradt, C., Hill, R., Aronson, M., Jarrell, B. E., Mueller, S. N., and Levine, E. M.:Cytogenetic evaluation of human endothelial cell cultures. J. Cell. Physiol. 132:453-462, 1987.
  pubmed

• 18) Schneider, E. L. and Fowlkes, B. J.:Measurement of DNA content and cell volume in senescent human fibroblasts utilizing flow multiparameter single cell analysis. Exp.Cell Res. 98:298-302, 1976.
  pubmed

• 19) Reis, R. J. and Goldstein, S.:Loss of reiterated DNA sequences during serial passage of human diploid fibroblasts. Cell 21:739-749, 1980.

• 20) Todaro, G. J. and Green, H.:Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313, 1963.

• 21) Shima, A. and Sugahara, T.:Age-dependent ploidy class changes in mouse hepatocyte nuclei as revealed by feulgen-DNA cytofluorometry. Exp.Geront. 11:193-203, 1976.

• 22) Thompson, K. V. A. and Holliday, R.:The longevity of diploid and polyploid human fibroblasts:Evidence against the somatic mutation theory of cellular ageing. Exp.Cell Res. 112:281-287, 1978.
  pubmed

P.339 掲載の参考文献

• 1) Baserga, R. et al:A study on the establishment and growth of tumor metasasis with tritiated thymidine. Cancer Res. 20:910, 1960.

• 2) Mendelsohn, M. L.:Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse, IV the growth fraction. J. Natl. Cancer Inst. 28:1015, 1962.

• 3) 野村和弘:Cell kinetics. 治療学 7:209, 1981.

• 4) Hoshino, T. et al:The distribution of nuclear DNA in human brain tumors. Acta Neurosurg. 40:13, 1978.

• 5) Kato, T. et al:Isolation of cell nuclei from the mammalian cerebral cortex and their assortment on a morphological basis. J. cell Biol, 32:649, 1967.
  pubmed

• 6) Ironside, J. W., et al:DNA in meningioma tissues and explant cell cultures-a flow cytometric study with clinicopathological correlations. J. Neurosurg. 66:588, 1987.
  pubmed

• 7) Cho, K. G., et al:Flow cytometric determination of DNA ploidy modality in human intracranial neoplasms

• 8) 野村和弘・他:脳腫瘍の悪性度とDNAパターン. Oncologia 20:42, 1986.

• 9) Kawamoto, K. et al:Flow cytometric analysis of the DNA distribution in human brain tumors. Acta Neuropathol. 46:39, 1979.
  pubmed

• 10) 野村和弘・他:脳腫瘍の生長解析. 神経研究の進歩 22:29, 1978.

P.349 掲載の参考文献

• 1) Brauch, H., et al:Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N. Engl. J. Med. 317:1109-1113, 1987.
  pubmed

• 2) Matsson, P. and Rydberg, B.:Analysis of chromosomes from human peripheral lymphocytes by flow cytometry. Cytometry. 1:369-372, 1981.
  pubmed

• 3) Collard, J. G., et al:Gene mapping by chromosome spot hybridization. Cytometry 6:179-185, 1985.
  pubmed

• 4) Sandberg, A. A.:Solid tumors and metastatic cancer. In:The Chromosomes in Human Cancer and Leukemia, Sandberg, A. A. (ed). Elsevier, New York, 1980, p.458-565.

• 5) Nesiell, M., et al.:Cytomorphological grading and Feulgen DNA-analysis of metaplastic and neoplastic bronchial cells. Cancer 41:1511-1521, 1978.

• 6) Pak, H. Y., et al:Quantitative DNA determinations by image analysis. I. Application to human pulmonary cytology. Analyt. Quant. Cytol. 4:95-98, 1982.

• 7) Adams, L. R. and Dahlgren, S. E.:Cytophotometric measurements of the DNA content of lung tumours, Acta Path. Microbiol. Scandinav. 72:561-574, 1968.

• 8) 井坂英彦:腫瘍細胞の形質, 染色体, 腫瘍病理学, 菅野晴夫, 小林博(編) 朝倉書店, 東京, 1970, p.111-122.

• 9) Atkin, N. B. and Kay, R.:Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Brit. J. Cancer 40:210-221, 1979.
  pubmed

• 10) Blondal, T. and Lindgren, A.:Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung:Relation of proliferative activity and DNA ploidy to prognosis. Analyt. Quant. Cytol. 4:225-232, 1982.

• 11) 磯部宏・他:原発性肺癌の核DNA量の測定-摘出新鮮検体とパラフィン包埋検体との比較-. 医学のあゆみ 142:351-352, 1987.
  Medical*Online

• 12) 水野重孝・他:Flow cytometryのための肺癌組織細胞分散法の検討-ペプシン消化法について-. 日臨細胞誌 26:621-627, 1987.

• 13) Barlogie, B., et al:Cellular DNA content as a marker of neoplasia in man. Am. J. Med. 69:195-203, 1980.

• 14) Raber, M., et al:Determination of ploidy abnormality and cell cycle distribution in human lung cancer using DNA flow cytometry. Proc. Amer. Associ. Cancer Res. 21:40, 1980.

• 15) Bunn, P. A., et al:Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res. 43:5026-5032, 1983.
  pubmed

• 16) Zimmerman, P. V., et al:Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet, II :530-533, 1987.

• 17) Olszewski, W., et al:Flow cytometry of lung carcinoma. A comparison of DNA stemline and cell cycle distribution with histology. Analyt. Quant. Cytol. 4:90-94, 1982.

• 18) Volm, M., et al:DNA distribution in non-small cell lung carcinomas and its relationship to clinical behaivor. Cytometry 6:348-356, 1985.

• 19) Bunn, P., et al.:Comparison of cytology and DNA content analysis by flow cytometry(FCM) in specimens from lung cancer patients. Proc. Amer. Associ. Cancer Res. 21:40, 1980.

• 20) Vindelφv, L. L., et al:Clonal heterogeneity of small cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res. 40:4295-4300, 1980.

• 21) Nowell, P. C.:The clonal evolution of tumor cell populations. Science 194:123-128, 1976.

• 22) Pegoraro, L., et al:A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B cell leukemia. Proc. Natl. Acad. Sci. USA. 81:7166-7170, 1984.

• 23) Baildam, A. D., et al:DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br. J. Cancer 55:553-559, 1987.
  pubmed

• 24) Levan, A. and Biesele, J. J.:Role of chromosomes in cancerogenesis, as studied in serial tissue culture of mammalian cells. Ann. N. Y. Acad. Sci. 71:1022-1053, 1958.
  pubmed

• 25) Stanley, K. E.:Prognostic factors in lung cancer. In:Lung Cancer, Aisner, J. (ed). Churchill Livingstone, New York, 1985, p.41-66.

• 26) Teodori, L, et al:Non-small cell lung carcinoma:Tumour characterization on the basis of flow cytometrically determined cellular heterogeneity. Cytometry 4:174-183, 1983.
  pubmed

• 27) Terz, J. J., et al:Anlysis of the cell kinetics of human solid tumors. Cancer 28:1100-1110, 1971.

• 28) Muggia, F. M., et al:Cell kinetics studies in patients with small cell carcinoma of the lung. Cancer 34:1683-1690, 1974.
  pubmed

• 29) Straus, M. J. and Moran, R. E.:Cell cycle parameters in hman solid tumors. Cancer 40:1453-1461, 1977.

• 30) Wilson, G. D., et al:The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 6:641-647, 1985.
  pubmed

• 31) Sasaki, K., et al:A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine. Cytometry 8:526-528, 1987.

P.357 掲載の参考文献

• 1) 佐々木切典:消化器癌のDNAy解析. 最新医学 40:85-87, 1985.

• 2) Hedley, D. W., et al.:Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31:1333-1335, 1983.
  pubmed

• 3) Petrova, A. S., et al.:Flow cytometry, cytomorphology and histology in gastric carcinoma. Oncology 37:318-324, 1980.

• 4) Teodori, et al.:Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry 5:63-70, 1984.
  pubmed

• 5) Macartney, I. C., et al.:DNA flow cytometry of histological material from human gastric cancer. J. Pathol. 148:273-277, 1986.

• 6) Ballantyne, K. C., et al.:Flow cytometric analysis of the DNA content of gastric cancer. Br. J. Cancer 56:52-54, 1987.
  pubmed

• 7) Deinlein, E., et al.:DNA flow cytometric measurements in inflammatory and malignant human gastric lesions. Virchows Archiv. Pathol. Anat. 402:185-193, 1983.
  pubmed

• 8) Van, den, Ingh, H. F., et al.:Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res. 45:3392-3397, 1985.
  pubmed

• 9) Weiss, H., et al.:Characterization of human adenomatous polyps of the colorectal bowel by means of DNA distribution patterns. Oncology 42:33-41, 1985.
  pubmed

• 10) Banner, B. A., et al.:Multiparameter flow cytometric analysis of colon polyps. Am. J. Clin. Pathol. 87:313-318, 1987.
  pubmed

• 11) Hammarberg, C., et al.:Early detection of malignancy in ulcerative colitls. Cancer 53:291-295, 1984.
  pubmed

• 12) Wolley. R. C., et al.:DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J. Natl. Cancer. Inst. 69:15-22, 1982.
  pubmed

• 13) Banner, B. F., et al.:Should flow cytometric DNA analysis procede definitive surgery for colon carcinoma. Ann. Surg. 200:740-744, 1985.

• 14) Frankfurt, O. S., et al.:Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry 5:71-80, 1984.
  pubmed

• 15) Tribukait, B., et al.:Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukesclassification and to histopathological differentiation. Acta. Patnol. Microbiol. Immunol. Scand. Sect. A 91:89-95, 1983.

• 16) Petersen, S. E., et al:Flow-cytometric demonstration of tumour cell subpopulations with differen DNA content in human colo-rectal carcinoma. Eur. J. Cancer 15:383-386, 1978.

• 17) Armitage, N. C., et al.:The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br. J. Surg. 72:828, 1985.
  pubmed

• 18) Finan, P. J., et al.:Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer. Br. J. Cancer 54:327-330, 1986.
  pubmed

P.376 掲載の参考文献

• 1) Danielsen, H., et al:A method for determing ploidy distribution in liver tissue by stereological analysis of nuclear size calibrated by flow cytometric DNA analysis. Cytometry 7:475, 1986.

• 2) 山口 秀則・他:肝再生時における肝細胞およびKupffer細胞の細胞動態について-フローサイトメトリーによる解析. 肝臓 in press.

• 3) Digernes, V., et al:Flow cytometric of nuclear DNA content in liver cirrhosis and liver tumors in rats exposed to acetylaminofiuorence. Virchows Arch(Cell Pathol). 47:139, 1984.

• 4) 草野 満夫:フローサイトリーによるヒト肝硬変, 肝癌細胞のDNA Cell Kinetics解析-その有用性と測定上の問題点について-. 日本消化器病学会雑誌 (Suppl.) 84:2065, 1987.

• 5) Vindelov, L.L., et al:A detergent-tripsin method for the Preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323, 1983.
  pubmed

• 6) Vindelov, L.L., et al:Long-term strorage of samples for flowcytometric DNA analysis. Cytometry 3:317, 1982.

• 7) 紀野 修一・他:パラフィン包理肝組織を用いた肝細胞核DNA量の測定法と解析上の問題点. 肝臓 29:1988. (in press)

• 8) Hedley, D., et al:Method for analysis of cellular DNA content of paraffin-embedded pathological materials using flow cytometry. J. Histchmi. &Cytochemi. 31:1333, 1983.

• 9) Teodori, L., et al:Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry 5:63, 1984.
  pubmed

• 10) Kodal, W., et al:Tumor DNA content in the prognosis of colorectal carcinoma. JAMA. 225:3123, 1986.

• 11) Friedlander, M., et al:Influence of cellular DNA content on survival inadvanced ovarian cancer. Cancer Res. 44:397, 1984.

• 12) 紀野 修一:肝部分切除後の肝実質細胞の増殖に及ぼす副交感神経性因子の役割. 肝臓 29:1988. (in press)

P.389 掲載の参考文献

• 1) 杉田道夫・他:Flow cytometry および顕微蛍光測光法による子宮頸部扁平上皮癌細胞の形態と核DNA量の相関. 日臨細胞会誌 23(4) :503-508, 1984.

• 2) 杉田道夫・他:FCM(fiow cytometry)によるDNAパターンからみたcisplatin療法の効果判定. 最新医学 39(8) :1719-1721, 1984.

• 3) 天神美夫・他:Flow cytometryからみた子宮癌の細胞像. 最新医学 40(1) :126-129, 1985.
  Medical*Online

• 4) Tribukait, B.:Clinical DNA Flow Cytometry. Med. Oncol. & Tumor Pharmacother. 1(4) :211-218, 1984.
  pubmed

• 5) Barlogie, B., et al:Prognostic Implications of Ploidy and Proliferative activity in Human Solid Tumors. Cancer Genetics and Cytogenetics 6:17-28, 1982.
  pubmed

• 6) 阪口耀子・他:Flow cytometryのための組織細胞分散法の確立. 日臨細胞会誌 22(2) :228-234, 1983.

• 7) 杉田道夫・他:核DNA分析における新しい組織分散法の応用. 癌の臨床 28(13) :1530-1536, 1982.

• 8) Hedley, D. W., et al:Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31:1333-1335, 1983.
  pubmed

• 9) 磯部 宏・他:paraffin包埋組織のFlow cytometryによる核DNA量の測定法. 癌と化学療法 14(6) :1944-1946, 1987.
  Medical*Online

• 10) Jakobsen, A. et al:DNA distribution in Biopsy Specimens from Human Cervical Carcinoma Investigated by Flow Cytometry. Virchows Arch. B. Cell Path. 29:337-342, 1979.

• 11) Jakobsen, A., et al:Flow Cytometric Classification of Biopsy Specimens from Cervical Intraepithelial Neoplasia. Cytometry 4:166-169, 1983.
  pubmed

• 12) Jakobsen, A., et al:DNA Distribution and Chromosome Number in Human Cervical Carcinoma. Analytical and Quantitative Cytology 5(1) :13-18, 1983.
  pubmed

• 13) Jakobsen, A.:Prognostic impact of ploidy level in carcinoma of the cervix. Am. J. Clin. Oncol. 7:475-480, 1984.
  pubmed

• 14) Rutgers, D. H. et al:DNA-flow cytometry of squamous cell carcinomas from the human uterine cervix. Radiation and Oncology 7:249-258, 1984.

• 15) Strang, P. et al:Flow cytometric DNA patterns in cervical carcinoma Acta. Radiologica Oncology 25:249-254, 1986.
  pubmed

• 16) Willen, R. et al:Prospective Malignancy Grading and Flow Cytometry DNA Distribution in Biopsy Specimens from Invasive Squamous Cell Carcinoma of the Uterine Cervix. Anticancer Research 7:235-242, 1987.
  pubmed

• 17) Dudzinski, M. R. et al:DNA Content in Cervical Neoplasia and Its Relationship to Prognosis, Obstet. & Gynecol. 69(3) :373-377, 1987.

• 18) 副島研爾:子宮頸部の異型上皮, 上皮内癌及び浸潤癌の核DNAに関する研究. 日産婦誌 26(12) :1333-1341, 1974.

• 19) 後藤忠雄:産婦人科領域における膣内組織片及び培養細胞の核内DNA定量に関する研究. 日産婦誌 20(4) :375-384, 1968.

• 20) 杉田道夫・他:子宮内膜癌における核DNA量と細胞形態の相関に関する研究. 日産婦誌 38(3) :195-202, 1986.

P.407 掲載の参考文献

• 1) Buchner, T., et al:Die Impulscytophotometrie in der hamatologischen Cytologie. Klin. Wochenschr 49:1090, 1971.

• 2) Adams, L. R., et al:Machine characterization of human leukocytes by acridine orange fuorescence. Acta Cytol. 15:289, 1971.

• 3) Kaplow, L. S.:Leukocyte peroxidase and nonspeciffic esterase. In:Flow cytometry and Sorting, Melamed, M. R., Mullaney, P. F., Mendelsohn, M. L. (eds). John. Wiley and Sons, New York, 1979, p.531.

• 4) Tanke, H. J., et al:Flow cytometry of human reticulocytes based on RNA fluorescence. Cytometry 1:313, 1980.

• 5) Mendelsohn, M. L., et al:The detection and sorting of rare sickle-hemoglobin containing cells in normal human blood. In:Flow Cytometry IV, Laerum, O. D., Lindmo, T., Thorud, E. (eds.). Universitetsforlaget, Bergen-Oslo-Trondheim, 1980, p.311.

• 6) Howard, R J., et al:Plasmodium-infected blood cells analyzed and sorted by flow fluorimetry with the deoxyribonucleic acid binding dye 33258 Hoechst. J. Histochem, Cytochem 27 :803, 1979.
  pubmed

• 7) van den Engh, G., et al:Concentration of hemopoietic stem cells using a light-activated cell sorter. Blood Cells 6:609, 1980.
  pubmed

• 8) Grogan, W. M., et al:Applications of light scatter to separation of stem cells. Blood Cells 6:625' 1980.
  pubmed

• 9) Bassoe, C-F., et al:Quantitation of single cell phagocytic capacity by fow cytometry. In:Flow Cytometry IV, Laerum, O. D., Lindmo, T., Thorud, E. (eds) Universitetsforlaget, Bergen-Oslo, Trondheim, 1980, p.170.

• 10) Nakeff, A.:Flow cytometric analysis of megakaryocytopoiesis:Strategy for defining mitotic and endoreduplicative events in the committed progenitor compartment. Blood Cells 6:665, 1980.
  pubmed

• 11) 高本 滋 :腫瘍マーカーとしてのDNA aneuploidyの検索. 関西フローサイトメトリー 6:3, 1987.

• 12) 高本 滋・他 :FCMによる腫瘍マーカーとしての異数倍数体の検索. -第一報, 標準試料について-. 日血会誌 47:308, 1984.

• 13) 鈴木伸行・他:腫瘍マーカーとしての異数倍数体の検索, ニジマス赤血球およびRNase処理について. FCM・Cell Biology研究会抄録 3:41, 1985.

• 14) 高本 滋・他:FCMによる異数倍数体の検索と染色体分析との相関. 日本癌学会総会記事 44:221, 1685.

• 15) Barlogie, B., et al:Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma. Cancer Res. 37:4400, 1977.
  pubmed

• 16) Hiddemann, W., et al:Convention on nomenclature for DNA cytometry. Cytometry 5:445, 1984.

• 17) Krishan, A.:Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188, 1975.

• 18) Vindelov, L. L., et al:Standardization of high-resolution flow cytometric DNA-analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 3:328, 1983.
  pubmed

• 19) Andreeff, M., et al:Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55:282, 1980.
  pubmed

• 20) 高本 滋:FCM による腫瘍マーカーとしての異数倍数体の検索, -ATLを中心に-, 末舛恵一監修. 下山正徳編集, ATLおよび周辺疾患の染色体異常. 協和企画通信, 東京, pp.1-17, 1985.

• 21) 高本 滋・他:白血病における腫瘍マーカーとしてのDNA aneuploedyの臨床的意義. 日本癌学会総会記事 45:527, 1986.

• 22) Diamond, L. W., et al:Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 50:1122, 1982.
  pubmed

• 23) Barlogie, B., et al:Flow cytometry in clinical cancer research. Cancer Research 43:3987, 1983.

• 24) 田原 徹・他:FCMを用い異数倍数体を腫瘍マーカーとして興味ある経過を観察し得た白血病2症例. 日血会誌 48:389, 1985.

• 25) Bloomfield, C. D., et al:Nonrandom Chromosome abnormalities in lymphoma. Cancer Res. 43:2975, 1983.
  pubmed

• 26) Shackney, S. E., et al:Dual parameter flow cytomesry studies in human lymphomas. J. Clin. Invest. 66:1281, 1980.
  pubmed

• 27) Drewinko, B., et al:Effects of chemotherapy on the labeling index of myeloma cells. Cancer 34:526, 1980.

• 28) Sandberg, A. A.:The chromosomes in human cancer and leukemia. vol.15, pp.416 Elsevier. New York, 1980.

• 29) Latreille, J., et al:Cellular DNA content as a marker of human multiple myeloma. Blood 55:403, 1980.
  pubmed

• 30) Latreille, J., et al:Ploidy and proliferative characteristics in monoclonal gammopathies. Blood 59:43, 1982.
  pubmed

• 31) Bunn, Jr., P. A., et al:Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma:Clinical implications. Blood 59:528, 1982.

• 32) Lewensohn, R., et al:DNA content of human myeloma cells. Eur. J. Cancer Clin. Oncol. 19:59, 1983.

• 33) Braylan, R. C., et al:Flow analysis of hairy cell leukemia. Leukemia Res. 4:177, 1980.
  pubmed

• 34) Bunn, Jr., P. A., et al:DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sezary syndrome. J. Clin. Invest. 65:1440, 1980.

• 35) Rosenthal, S., et al:Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J. Med. 63:542, 1977.
  pubmed

• 36) Brodeur, G. M., et al:Near-haploid acute lymphoblastic leukemia:A unique subgroup with a poor prognosis?. Blood 58:14, 1981.
  pubmed

• 37) 太田和雄・他:癌細胞の動態と治療法との関係, 癌の科学5. 癌の制圧-最近の治療学-. 太田邦夫・他編, pp.19. 南江堂. 東京. 1979.

• 38) 太田和雄:II. 3H-サイミジンの血液学への応用. a. 白血病および腫瘍における細胞回転. 日本血液学会雑誌 27:693, 1964.

• 39) Aardal, N. P., et al:Sequential flow cytometric analysis of cellular DNA-content in peripheral blood during treatment for acute leukaemia. Scand. J. Haematol. 22:25, 1979.
  pubmed

• 40) 高本 滋:Flow-micro-fluorometer(F.M.F.)他による白血病細胞回転に関する研究(第1報). 日本臨床血液学会総会抄録, 149, 1976.

• 41) 御供泰治・他:Flow microfluorometryによる慢性骨髄性白血病の細胞回転に関する研究(第1報). 日本血液学会雑誌 41:859, 1978.

• 42) Dosik, G. M., et al:Pretreatment flow cytometry of DNA content in adult acute leukemia. Blood 55:474, 1980.
  pubmed

• 43) Hillen, H., et al:Value of pulse-cytophotometry for diagnosis and prognosis in acute leukemia. In:Pulse-Cytophotometry II, Gohde, W., Schumann, J., Buchner, T. (eds). European Perss Medikon, Ghent, 1976, p.392.

• 44) Scarffe, J. H., et al:Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukemia of childhood. Brit. J. Cancer.
  pubmed

• 45) 椿 和央・他:Flow cytomertyによる白血病細胞の増殖動態観察と治療への応用. 臨床血液 22:1916, 1981.

• 46) Haanen, C.:Limitations and achievements of DNA-flow cytometry in monitoring human leukemias. In:Flow Cytometry IV, Laerum, O. D., Lindmo, T., Thorud, E, (eds). Universitetsforlaget, Bergen-Oslo-Trondheim, 1980. p.492,

• 47) Braylan, R. C., et al:Selective flow cytometric analysis of neoplastic and non-neoplastic cell populations of human B cell lymphomas. Basic. Appl. Histochem. 24:365, 1980.

• 48) Scarffe, J. H., et al:Pretreatment cell kinetic studies in human lymphoid malignancies as possible prognostic factors. In:Pulse-Cytophotometry III, Lutz, D. (ed). European Press Medikon, Ghent, 1978, p.675.

P.417 掲載の参考文献

• 1) Williams, D. L., et al:Prognostic importance of chromosome number in 136 untreated children with acute lymphoblasic leukemia. Blood 60:864-871, 1982.

• 2) Look, A. T., et al:Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 65:1079-1086, 1985.
  pubmed

• 3) Worman, B., et al:Prognostic significance of DNA aneuploidy in childhood All. Proceedings of AACO 3:200, 1984.

• 4) Smets, L. A. et al:Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukemia of childhood. Br. J. Haemat. 61:113-123, 1985.

• 5) 鶴沢正仁・他:小児急性白血病のDNA aneuploidy. 臨床血液 26:1614-1620, 1985.

• 6) 鶴沢正仁・他:小児急性リンパ性白血病におけるDNA aneuploidyの臨床的意義の検討. 臨床血液 27:158-164, 1986.

• 7) 鶴沢正仁・他:フロー・サイトメトリーによる小児急性リンパ性白血病細胞のcommon ALL抗原とDNA量の同時解析. 臨床血液 27:738-746, 1986.

• 8) 片野直之・他:フローサイトメトリーによる小児急性白血病細胞の細胞動態の解析. 臨床血液 28:1971-1977, 1987.

• 9) Tsurusawa, M., et al:Prognostic implication of cellular DNA content in acute lymphoblastic leukemia. Am. J. Pediatr. Hematol. Oncot. 印刷中

• 10) Scarfee, J. H., et al:Relationship between the pretreatment proliferative activity of marrow blast cell and prognosis of acute lymphoblastic leukemia of childhood. Br. J. Cancer 41:764-771, 1980.

• 11) Look, A. T., et al:Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood 60:959-967, 1982.
  pubmed

• 12) Suarez, C., et al:DNA and RNA determination in 111 cases of childhood acute lymphoblastic leukemia(ALL) by flow cytometry:correlation of FAB classification with DNA stemline and proliferation. Br. J. Haemat. 60:667-686, 1985.

• 13) Andreeff., et al:Multiparameter flow cytometory for determination of ploidy, proliferation and differentiation in acute leukemia. Tumor aneuploidy (ed. by T. Buchner., et al, pp.81-105, springer-Verlag:Berlin Heiderberg, 1985.

• 14) Render, A., et al:Recognition of central nervous system leukemia by flow cytometry. Cytometry 5:614-618, 1984.

• 15) Williams, D. L, et al:Chromosome translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205-212, 1986.
  pubmed

P.430 掲載の参考文献

• 1) Dean, P. N. et al:The analysis and interpretation of DNA distributions measured by flowcytometry. Cytometry 3:188-195, 1982.

• 2) Tachibana, M. et al:Heterogeneity index score(HIS) :New computerized method for classification of human bladder carcinomas using flow cytometry. Urology 26:355-361, 1985.

• 3) Ljungberg, B. et al:DNA content in renal cell carcinoma with reference totumor heterogeneity. Cancer 56:503-508, 1985.

• 4) Otto, V. et al.:Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J. Urol. 132:237-239, 1984.

• 5) Chin, J. et al:Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J. Urol. 133:582-585, 1985.
  pubmed

• 6) Frankfurt, O. S. et al:Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometrpt 5:71-80, 1984.
  pubmed

• 7) Schwabe, H. W. et al:Flow-cytometric studies in renal carcinoma. Urol. Res. 11:121-125, 1983.

• 8) Baish, H. et al:DNA content of human kidney carcinoma cells in relation to histological grading. Br. J. Cancer 45:878-886, 1982.

• 9) Bennington, J. L. et al.:DNA cytometry on four-micrometer sections of paraffin-embedded human renal adenocarcinomas and adenomas. Cytometry 4:31-39, 1983.
  pubmed

• 10) 橘 政昭・他:泌尿器科領域におけるflow cytometryの臨床応用. 第4報:腎細胞癌予後規定因子としてのflow cytometric DNA-histogramの意義. 日泌尿会誌 78:816-821, 1987.

P.437 掲載の参考文献

• 1) Vindelov, L. L.:Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchow Arch. B. Cell Path. 24:227, 1977.

• 2) Tribukait, B., et al:The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors. A study of 100 untreated cases. Brit. J. Urol. 54:130, 1982.
  pubmed

• 3) 吉川和行・他:Flow Cytometryによる膀胱腫瘍の研究, 第2報:Flow cytometric DNA analysisによる膀胱腫瘍の予後と腔内再発の解析. 日泌尿会誌 78:227, 1987.

• 4) 吉川和行:Flow Cytometryによる膀胱腫瘍の研究, 第1報:Flow cytometric DNA analysisによる膀胱癌の悪性度評価の試み. 日泌尿会誌 76:483, 1985.

• 5) Gustafson, H., et al:The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand. J. Nephrol. 16:141, 1982.

• 6) Klein, F. A., et al:Flow cytometry of normal and nonneoplastic diseases of the bladder:An estimation of the false positive rate. J. Urol. 127:946, 1982.

• 7) deVere White, R., et al:The role of flow cytometry in urologic disease. Semin. Urol. 3:132, 1985.
  pubmed

• 8) Farsund, T., et al:Local chemotherapeutic effects in bladder cancer demonstrated by selective sampling and flow cytometry. J. Urol. 131:22, 1984.
  pubmed

• 9) Staiano-Coico, L., et al:Monitoring intravesical Bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry. J. Urol. 133:786, 1985.
  pubmed

P.448 掲載の参考文献

• 1) Stanners, C. P. and Till, J. E.:DNA synthesis in individual L-strain mouse cells. Biochem. Biophys. Acta. 37:406, 1960.
  pubmed

• 2) Howard, A. and Pelc, S. R.:Synthesis of desoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity, Suppl. 6:261, 1953.

• 3) Watanabe, I. and Okada, S.:Effects of temperature on growth rate of cultured mammalian cells(L5178Y) J. Cell Biol. 32:309, 1967.
  pubmed

• 4) Baisch, H., et al:Analysis of PCP-data to determine the fraction of cells in the various phases of cell c ycle. Radiat. Environ. Biophys. 12:31, 1975.

• 5) Dean, P. N. and Jett, J. H.:Mathematical analysis of DNA distributions derived from now microfluorometry. J. Cell Biol. 60:523, 1974.

• 6) Christensen, I, et al:Statistical analysis of DNA distributions from cell populations with partial synchrony. In "Third International Symposium on Pulse-Cytophotometry", Ed. D. Lutz, p.71. European Press, Ghent, 1978.

• 7) Dean, P. N.:A simplified method of DNA distribution analysis. Cell Tissue Kinet. 13:299, 1980.
  pubmed

• 8) Lindmo, T. and Aarnaes, E.:Selection of optimal model for DNA histogram byanalysis of error of estimated parameters. J. Histochem. Cytochem. 27:297, 1979.

• 9) Baisch, H. and Beck, H. P.:Comparison of cell kinetic parameters obtained by flow cytometry and autoradiography. In "Biomathematics and Cell Kinetics", Eds. A. J. Valleron and P. D. M. Macdonald, p.411, Elsevier/North Holland, Amsterdam, 1978.

• 10) Fried, J.:Method for the quantitative evaluation of data from flow microfluorometry. Comput. Biomed. R63. 9:263, 1976.

• 11) Fried, J. and Mandel, M.:Multi-user system for analysis of data from flow cytometry. Comput. Prog. Biomed. 10:218, 1979.

• 12) Beck, H. P.:A new analytical method for determining duration of phases, rate of DNA synthesis and degree of synchronization from flow-cytometric data on synchronized populations. Cell Tissue Kinet. 11:139, 1978.
  pubmed

• 13) Johnston, D. A., et al:Automatic processing and interpretation of DNA distributions:Comparison of several techniques. Comput. Biomed. Res. 11:393, 1978.
  pubmed

• 14) Zietz, S. and Nicolini, C.:Flow microfluorometry and cell kinetics:A review. In "Biomathematics and Cell Kinetics", Eds. A. -J. Valleron and P. D. M. Macdonald, p.357, Elsevier/North Holland, Amsterdam, 1978.

• 15) Collins, J. M. et al:Different rate of DNA synthesis during the S phase of log phase HeLa S3, WI-38, and 2RA cells. J. Biol. Chem. 255:3585, 1980.

• 16) Takahashi, M.:A multichannel method for the analysis of DNA content distribution using flow cytometric data. Comptt. Biomed. Res. 14:506, 1981.

• 17) Jett, J. H.:Mathematical analysis of DNA histograms from asynchronous and synchronous cell populations. In "Third International Symposium on Pulse-Cytophotometry", Ed. D. Lutz, p. 93, European Press, Ghent, 1978.

• 18) Jett, J. H. and Gurley, L. R.:An improved sum-of-normals technique for cell cycle distribution analysis of flow cytometric DNA histograms. Cell Tissue Kinet. 14:413, 1981.
  pubmed

• 19) Zietz, S.:FPi analysis, I. Theoretical outline of a new method to analyzed time sequences of DNA histograms. Cell Tissue Kinet. 13:461, 1980.

• 20) Grey, J. W.:Cell cycle analysis from computer synthesis of deoxyribonucleic acid histograms. J. Histochem. Cytochem. 22:642, 1974.

• 21) Grey, J. W.:Cell cycle analysis of perturbed cell populations:Computer simulation of sequential DNA distributions. Cell Tissue Kinet. 9:499, 1976.

• 22) Watson, J. V.:The application of age distribution theory in the analysis of cytofluorometric DNA histogram data. Cell Tisstte Kinet. 10:157, 1977.

• 23) Grey, J. W., et al:Rapid cell cycle analysis by measurement of the radioactivity in a narrow window in S phase (RCSi). Cell Tissue Kinet. 10:97, 1977.

• 24) Bohmer, R. -M.:Determination of nonproliferating cells in culture by combining flow cytometry with stathomokinetics. Cell Tissue Kinet. 13:497, 1980.
  pubmed

• 25) Wu, A. M.:Amethod for measuring the generation time and length of DNA synthesizing phase of clonogenic cells in a heterogenous population. Cell Tissue Kinet. 14:39, 1981.

• 26) Dosik, G. M.:A rapid automated stathomokinetic method for determination ofin vitro cell cycle transit time. Cell Tissue Kinet. 14:121, 1981.

• 27) Baisch, H. et al:A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet. 15:235, 1982.
  pubmed

• 28) 渡部郁雄:細胞動態・分化の解析. "フローサイトメトリー・ハンドブック". 天神, 高橋, 野村篇, 第3部第1章, p.214, サイエンスフォーラム, 東京, 1984.

• 29) 渡部郁雄:データ解析法・概論, "フローサイトメトリー-手技と実際"-. 第7章, p.515, 蟹書房, 東京, 1984.

• 30) 高橋 学:データ解析法・DNA分布の解析. "フローサイトメトリー手技と実際-". 第7章, p.529, 蟹書房, 東京, 1984.

P.466 掲載の参考文献

• 1) Bruce, W. R., et al:Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. Nat. Cancer Inst. 37:233, 1966.
  pubmed

• 2) Bhuyan. B. K., et al:Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells. Cancer Res. 37:1057, 1977.
  pubmed

• 3) Sinclair, W. K.:Hydroxyurea. Effects on chinese hamster cells grown in culture. Cancer Res. 27:297, 1967.
  pubmed

• 4) 太田和雄・他:癌細胞の動態と治療法の関係, 「癌の科学, 5, 癌の制圧-最近の治療学-」太田邦夫他編, pp.19, 南江堂, 東京, 1979.

• 5) Baisch, H., et al:A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kinet. 15:235, 1982.
  pubmed

• 6) Fried, J., et al. Multi-user system for analysis of data from flow cytometry. Comput. Programs Biomed. 10:218, 1979.
  pubmed

• 7) 野村和弘・他:悪性脳腫瘍の化学療法への応用. 癌と化学療法 9:1151, 1982.
  Medical*Online

• 8) Takamoto, S., et al:Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells. The 13th Internatiollal Congress of Chemotherapy proceedings. P. S. 12, 4, 8, -7, 1983.

• 9) 高本 滋・他:抗癌性抗生物質の細胞回転に及ぼす影響-Flow microfluorometry分析による-. 癌と化学療法 6:59, 1979.

• 10) 高本滋・他:Cell Kineticsよりみた抗白血病剤の選択. 医学と薬学 10:351, 1983.
  Medical*Online

• 11) 高本滋・他:F.M.F.による制癌剤の作用機序に関する研究, 第6報-代謝拮抗剤, アルカロイドを中心に-. 日本血液学会誌 41(2) :298, 1978

• 12) 高本滋・他:F.M.F.による制癌剤の作用機序に関する研究, 第8報-アルキル化剤を中心に-. 日本癌学会総会記事:140, 1978.

• 13) Krishan, A., et al:Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. Cancer Res., 36:3813, 1976.
  pubmed

• 14) Smets, L. A., et al:Early responses to chemotherapy detected by pulse cytophotometry, Brit. J. Cancer 34:153, 1976.
  pubmed

• 15) Kremer, W. B., et al:An attempt at synchronization of bone marrow cells in acute leukemia, Relationship to therapeutic response. Cancer 37:390, 1976.
  pubmed

• 16) Kufe, D. W., et al:High dose thymidine infusion in patients with leukemia and lymphoma. Blood 55:580, 1980.
  pubmed

• 17) 高本滋・他:FMF(Flow microfluorometry)によるcell cycleの解析, 現代臨床機能検査. 日本臨牀 37:1561, 1979.

• 18) 高本滋・他:抗癌剤の細胞回転に及ぼす影響. 「フローサイトメトリーハンドブック」, 天神美夫・他編, pp.314, サイエンスフォーラム社, 東京, 1984.

• 19) 高本滋・他:FCM分析によるTHP-adriamycinの細胞回転に及ぼす効果-Adriamycinとの比較-. 癌と化学療法 13:1868, 1986.
  Medical*Online

P.479 掲載の参考文献

• 1) Wright, J. C. et al:Investigation of the relation between clinical and tissue culture to chemotherapeutic agents on human cancer. New Eng. J. Med. 257:1207, 1957.
  pubmed

• 2) Holms, H. L., et al:Tissue culture microtest for predicting response of human cancer to chemothrapy. Lancet 985, 1974.

• 3) 下山正徳:培養株の薬剤感受性測定とその臨床的意義. 組織培養 6:142, 1980.

• 4) Rosenblum, M. L., et al:Development of a clonogenic cell assay for human brain tumors. Cancer 41:2305, 1978.
  pubmed

• 5) Povlsen, C. O., et al:Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res. 35:2790, 1975.
  pubmed

• 6) Shimosato, et al:Transplantation of human tumors in nude mice. J. Natl. Cancer Inst. 56:1251, 1976.
  pubmed

• 7) 野村和弘・他:悪性脳腫瘍の化学療法への応用. 癌と化学療法 9:1151, 1982.
  Medical*Online

• 8) Nomura, K., et al:BCNU-induced perturbation in the cell cycle of 9L rat brain cells. Cancer Treat. Rep.62:747, 1978.
  pubmed

• 9) 太田和雄他:癌細胞の動態と治療法との関係. 癌の科学, 第5巻・癌の制圧 太田邦夫他編, p.19-58, 南江堂 1979.

• 10) 野村和弘:Cell Kinetics. 治療学 7:209, 1981.

• 11) Rosenblum, M. L., et al:In vivo clonogenic tumor cell kinetics following 1, 3-Bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Cancer Res. 36:3718, 1976.
  pubmed

• 12) Hoshino, T., et al:Cell kinetics of human gliomas. J. Neurosurgery 37:15, 1972.

• 13) Frederiksen, et al:Flow cytometry in tumors of the brain. Acta Neuropathol. 41:1979, 1978.

P.491 掲載の参考文献

• 1) 江藤秀雄:人体と放射線. 岩波全書 38, 1969.

• 2) Hoshino, T., et al:Chemotherapeutic implication of growth fraction and cell cycle time in glioblastoma. J. Neurosurg. 43:127, 1975.
  pubmed

• 3) Terasima, T., et al:Variation in several responses of HeLa cells to X-irradiation during the division cycle. Biophys. J. 3:11, 1963.

• 4) 設楽信行:脳腫瘍のCellular Synchronization-Radiation Therapyに関する基礎的研究ならびに臨床例の解析. 神経進歩 22:119, 1978.

• 5) 設楽信行・他:脳腫瘍-最近における治療の飛躍-. Medical Way 3:99, 1986.

• 6) Kosugi, Y., et al:Computer aided analysis of cell-cycle phase from cytophoto-metric histogram. IEEE Transaction on Biomedical Engineering 25:429, 1978.

• 7) Tsuruo, T., et al:Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res. 43:2905, 1983.
  pubmed

• 8) Gratzner, H. G., et al:Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine:A new reagent for detection of DNA replication. Science 218, 474, 1982.
  pubmed

• 9) Kosugi, Y., et al:Graphical presentation of multidemensional flow histogram using hexagonal segmentation. Cytometry 7:291, 1986.

• 10) Genka, S., et al.:Cell cycle perturbation of cultured C6 glioma cells following short-term contact with a low dose of ACNU. Cytometry 8. 386, 1987
  pubmed

• 11) 源河 茂・他:新しい二次元標示法を用いた脳腫瘍細胞動態の解析. 医学のあゆみ 141:859, 1986.

• 12) Pallavicini, M. G., et al:Cytokinetic properties of asynchronus and cytosine arabinoside perturbed murine tumors measured by simultanenous bromodeoxyuridine/DNA analyses. Cytometry 6:602, 1985.

• 13) Sasaki, K., et al:Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Cytometry 7:391, 1986
  pubmed

• 14) 呉 耀晨・他:ヒト脳腫瘍細胞に対するvincristineの効果-BrdU/DNA二次元標示法による解析-. 医学のあゆみ 142:777, 1987.
  Medical*Online

P.509 掲載の参考文献

• 1) O'Mally, B. W., et al:The receptor of steroid hormones. Science Am. 234:32, 1977.

• 2) Jensen, E. V., Jacobson, H. I.:Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 18:387, 1962.

• 3) McCarty, K. S. Jr., et al:Cytochemistry of sex steroid receptors:a critique. Breast Cancer Res. Treatment. 1:315, 1981.

• 4) McCary, K. S., et al:Steroid hormone receptors in the regulation of differentiation. Am. J. Pathol., 86:705, 1977.

• 5) Greene, G. L., et al:Monoclonal antibodies as probes for estrogen receptor detection characterization. J. Steroid Biochem. 16:353, 1982.
  pubmed

• 6) Kuramoto, H., et al:Establishment of a cell line of human end o-metrial adenocarcinoma in vitro. Am. J. Obstet. & Gyneol. 114:1012, 1978.

• 7) Vigon, F., et al:Effects of plasma estrogen sulfate in mammary cancer cells. Endocrinology 106:1079, 1980.

• 8) Kikuchi, Y., et al:Effects of calmodul in antagonists on human ovarian cancer proliferation in vitro. Biochem. Biophys. Res. Commun. 123:385, 1984.

• 9) OhsaWa, N., et al:KM 2210(Estradiol-chlorambucil conjugate), A possible target-oriented anticancer agent, Prog. of 13th International Congress of Chemotherapy, 1983.

• 10) Crissman, H. A., et al:Cell cycle analysis in 20 minutes. Science 184:1927, 1974.

• 11) Dean, P. N., et al:The analysis and interpretion of DNA distributions measured by flow cytometry. Cytometry 3:188, 1982.

• 12) Tannenbaum, E., et al:Measurement of cellular DNA mass by flow microfluorometry using abiological internal standard. J. Histochem, Cytochem. 26:145, 1978.

• 13) Leclercq, G., et al:Estrogen-linked cytotoxic agents of pothntial value for the treatment of breast cancer. In Hormone and Cacer. (eds. S. Lacobelli, et al.) 521, Ravan press, New York, 1980.

• 14) Verga, J. M., et al:Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melaoma cells. Nature 267:56:56, 1977.

• 15) Jonsson, G.:Treatment of advanced prostatie carcinoma with Estracyt. Scand. J. Urol. Nephrol. 5:103, 1971.
  pubmed

• 16) Muechler, E. R., et al:Interaction of the cytotoxic agent Estramustine phosphate(Estracyt) with the estrogen receptor of the human uterus. Gynecol. Oncol. 8:330, 1979.

• 17) Asai. M., et al:In vitro interation between steroid arkylating agents and oetrogen receptors in rabit uteri. Acta Endocrinol. 87:173, 1978.

• 18) 下山正徳:制癌剤のCell-Kill-Kineticsと至適投与法. 癌と化学療法 3:1103, 1976.
  Medical*Online

• 19) Carlstedt-Duke, J., et al:Immunochemical analysis of the glucocorticoid receptor:Identification of a third domain separated from the steroid binding and DNA-binding domains. Proc. Natl. Acad. Sci. USA. 79:4260, 1982.
  pubmed

• 20) 斉藤 怜・他:人子宮内膜腺癌細胞の同調培養とステロイドレセプター変動との相関. Folia Endocrinol. 61:1210, 1985.

• 21) Jakesz, R., et al:Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells. Cancer Res. 44:619, 1984.
  pubmed

• 22) 大沢仲昭・他:ホルモンを担体とした制癌剤:Bestrabucil(Estradiol-chrolanbucil複合体). 癌と化学療法 11:2115, 1984.

• 23) 西谷 巌・他:ステロイドホルモン標的癌細胞の増殖・分化と核内調節機構. Oncologia 8:110, 1984.

P.519 掲載の参考文献

• 1) Gratzner, H. G., Leif, R. C., Ingram, D. J. and Castro, A.:The use of antibody specific for bromodeoxyuridine for the immunofluorescent determination of DNA replication in single cells and chromosomes. Exp.Cell Res. 95:88, 1975.

• 2) Gratzner, H. G. and Leif, R. C.:An immunofluorescent method for monitoring DNA synthesis by fiow cytometry. Cytometry 1:385-389, 1981.

• 3) Dolbeare, F., Gratzner, H., Pallavicini, M. and Gray, J. W.:Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80:5573-5577, 1983.
  pubmed

• 4) 高橋 学, 佐々木功典, 村上知之:Bromodeoxyuridine標識による細胞動態の解析. 最新医学 40:80-84, 1985.
  Medical*Online

• 5) Moran, R., Darzynkiewicz, Staiano-Coico, L. and Melamed, M. R.:Detection of 5-bromodeoxyuridine(BrdUrd) incorporation by monoclonal antibodies. J. Histochem. Cytochem. 33:821-827, 1985.
  pubmed

• 6) Dolbeare, F., Beisker, W., Pallavicini, M. G., Vanderlaan, M. and Gray, J. W.:Cytochemistry for bromodeoxyuridine/DNA analysis:Stoichiometry andsensitivity. Cytometry 6:521-530, 1985.
  pubmed

• 7) Beisker, W., Dolbeare, F. and Gray, J. W.:An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Cytometry 8:235-239, 1987.
  pubmed

• 8) 村上知之, 佐々木功典, 荻野哲朗, 高橋学:DNA-BrdUrd同時測定のための技術的倹討. 関西フローサイトメトリー研究会機関誌 2:39-42, 1985.

• 9) Sasaki, K., Adachi, S., Yamamoto, T., Murakami, T., Tanaka, K. and Takahashi, M.:Effects of denaturation with HC1 on the immunological stainingof bromodeoxyuridine incorporated into DNA. Cytometry 9:93-96, 1988.

• 10) 村上知之, 足立史朗, 山本健, 佐々木功典, 高橋学:BrdU染色の至適条件の決定I. BrdU法による螢光のstoichiometry. (第5回 FCM・Cell Biology研究会発表)

• 11) Sasaki, K., Murakami, T., Ogino, T., Takahashi, M. and Kawasaki, S.:Flowcytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Cytometry 7:391-395, 1986.

• 12) Sasaki, K., Murakami, T. and Takahashi, M.:A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine. Cytometry 8:526-528, 1987.

P.528 掲載の参考文献

• 1) Cleaver, J. E.:Thymidine Metabolism and Cell Kinetics. North Holland Pub. Co., Amsterdam 1967.

• 2) Baserga, R. (ed) :The Cell Cycle and Cancer. Marcel Dekker, INC, New York 1971.

• 3) Steel, G. G.:Growth Kinetics of Tumours. Clarendon Press, Oxford 1977.

• 4) Nelson, J. S. R., et al:Autoradiographic detection of DNA polymerase containing nuclei in sarcoma 180 ascites cells. Cell Tissue Kinet. 6:45, 1973.

• 5) Miyauchi, K., et al :Autoantibody to a nuclear antigen in proliferating cells. J. Immunol 121:2228, 1978.

• 6) Gerdes, J., et al:Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31:13, 1983.
  pubmed

• 7) Goz, B.:The effects of incorporation of 5-halogenated deoxyruidine into the DNA of eukaryotic cells. Pharmacol Rev. 29:249, 1978.

• 8) Szybalski, W.:X-ray sensitization by halopyrimidines. Cancer Chemother. Rep.58:539, 1974.
  pubmed

• 9) Gratzner, H. G.:Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine:a new reagent for detection of DNA replication. Science 218:474, 1982.
  pubmed

• 10) Vanderlaan, M., et al:Improved high-affinity monoclonal antibody to iododeoxyuridine. Cytometry 7:499, 1986.
  pubmed

• 11) Hedley, D. W., et al:Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytomerty. J. Histochem. Cytochem. 31:1333, 1983.

• 12) Nagashima, T., et al:Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta. Neuropathol. 67:155, 1985.
  pubmed

• 13) Hoshino, T., et al:Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 6:627, 1985.
  pubmed

• 14) Sugihara, H., et al:Immunohistochemical detection of bromodeoxyuridine in formalin-fixed tissues. Histochem. 85:193, 1986.

• 15) Hayashi, Y., et al:The effects of fixation time and enzymatic digestion on the immunohistochemical demonstration of bromodeoxyuridine in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 1988(in press).

• 16) Hoshino, T, , et al:S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. Int. J. Cancer 38:369, 1986.
  pubmed

• 17) Kriss, J. P., et al:The distribution and fate of bromodeoxyuridine in the mouse and rat. Cancer Res. 22:254, 1962.
  pubmed

• 18) Kinsella, T. J., et al:A phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. Int. J. Radiat Oncol. Biol. Phys. 10:69, 1984.
  pubmed

• 19) Russo, A., et al:Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Cancer Res. 44:1702, 1984.
  pubmed

• 20) Zhang, R. X., et al:Cytotoxic effect and induction of sister chromatid exchange in exponentially growing rat 9L gliosarcoma cells after brief exposure to BrdU. Cell Tissue Kinet 20:357, 1987.
  pubmed

• 21) Hoshino, T., et al:Cell kinetic analysis of human malignant brain tumors. Cancer 44:956, 1979.
  pubmed

• 22) Cho, K. G., et al:Proliferative potential of malignant and non-malignant meningiomas. in Chatel, M., Darcel, F. &Pecker, J. eds. "Brain Oncology" Martinus Nijhoff Pub., Dordrecht pp.79, 1987.

• 23) Nagashima, T., et al:Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry on brain tumors. J. Neurosurg. 1988 (in press).

P.538 掲載の参考文献

• 1) Humburger, A. W. and Salmon, S. E.:Primary bioassay of human tumor cells. Science(Wash D. C.) 197:461-463, 1977.

• 2) Salmon, S. E.:Human tumor colony assay and chemosensitivity testing. Cancer Treatment Rep.68:117-125, 1984.

• 3) Von Hoff, D. D., Casper, J. E., Sandbach, J. et al:Association between humantumor colony-forming assay results and response of an individual patientstumor to chemotherapy. Am. J. Med. 70:1027-1032, 1981.

• 4) Sasaki, K.:Measurement of tritiated thymidine labeling index by incubation invitro of surgically removed cervical cancer. Gann 68:307-313, 1977.

• 5) Dolbear, F., Gratzner, H., Pallavicini, M. G. et al:Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA. 80:5573-5577, 1983.

• 6) 野村和弘, 渋井壮一郎, 渡辺 卓:フローサイトメトリーの癌臨床への応用-悪性脳腫瘍の化学療法への応用. 癌と化学療法 9:1151-1163, 1982.

• 7) 藤本 茂, 奥井勝二:Isotopeを用いた感受性test. 癌と化学療法 9:582-589, 1982.

• 8) Samfilippo, O.:Estimation of differential in vitro sensitivity of non-Hodgkin lymphoma to anticancer drugs. Europ.J. Cancer 17:217-226, 1981.

P.556 掲載の参考文献

• 1) Gusella, J. F., Keys, C., Varsanyi-Breiner, A., Kao, F. T., Jones, C., Puck, T. T., and Housman, D.:Isolation and localization of DNA segments fromspecific human chromosomes. Proc. Natl. Acad. Sci. U.S.A. 77:2829, 1480.

• 2) Schmeckpeper, B. J., Smith, K. D., Dorman, B. P., Ruddle, F. and Conover, C. C.:Partial Purification and characterization of DNA from the human Xchromosome. Proc. Natl. Acad. Sci. U.S.A. 75:6525, 1979.

• 3) Carrano, A., Van Dilla, M. A., Gray, J. W.:Flow cytogenetics:A new approach to chromosome analysis, In "Flow cytometry and cell Sorting" eds. Mendelsohn, M. L., Melamed, M. R. and Mullaney, P. E. (Wiley, New York), p.421.

• 4) Gray, J. W., Carrano, A. V., Steinmetz, L. L., Van Dilla, M. A., Moore, D. H., Mayall, B. H., Mendelsohn, M. L.:Chromosome measurement and sortingby flow systems. Proc. Natl. Acad. Sci. U.S.A. 72:1231, 1975.
  pubmed

• 5) Carrano, A. V., Gray, J. W., Langlois, R. G., Burkhart-Schultz, K. J., and Van Dilla, M. A.:Measurement and Purification of human chromosomes by flow cytometry and Sorting. Proc. Natl. Acad. Sci. U. S. A, 76:1382, 1979.

• 6) Sillar, R. and Young, B. D.:A new method for the preparation of metaphasechromosomes for Flow analysis. J. Histochem. Cytochem. 29:74, 1981.

• 7) Young, B. D., Fergusos-Smith, M. A., Sillar, R. and Boyd, E.:High resolutionanalysis of human peripheral lymphocyte chromosomes by now cytometry. Proc. Natl. Acad. Sci. U.S.A. 78:7727, 1981.

• 8) Otto, F. J., Oldiges, H., G6hde, W., Barlogie, B., Schumann, J.:Flow cytogenetics of uncloned and cloned chinese hamster. Cytogenet. Cell. Genet. 27:52, 1980.

• 9) Blumenthal, A. B., Dieden, J. D., Kapp, L. N. and Sedat, J. W.:Rapid isolationof metaphase chromosomes containing high molecular weight DNA. J. Cell Biology. 81:255, 1979.

• 10) Kuo, M. T.:Comparison of chromosomal structures isolated under differentconditions. Exp.Cell Res. 138:221, 1982.

• 11) Lebo, R. V.:Chromosome sorting and DNA sequence localization. Cytometry, 3:145, 1982.
  pubmed

• 12) Bijman, J. Th.:Optimization of mammalian chromosome suspension preparations employed in a flow cytometric analysis. Cytometry 3:354, 1983.

• 13) Carrano, A. V., Gray, J. W., Moore, D. H., Minklev, J. L., Mayall, B. H., Van Dilla M. A. and Mendelsohn, M. L.:Purification of the chromosomes of the indian muntjac by flow sorting. J. Histochom. Cytochem. 24:348, 1976.

• 14) Lebo, R. V., Carrano, A. V., Burkhart-Schultz, K., Dozy, A., Yu, L. G. and Kan, Y. W.:Assignment of humanβ-, γ- and δ-globin genes to the short arm of chromosome 11 by chromosome sorting and DNA restriction enzyme analysis. Proc. Natl. Acad. Sci. U.S.A. 75:5804, 1979.

• 15) Yu, L C., Aten. J., Gray, J. and Carrano, A. V.:Human chromosome isolationfrom short-term lymphocyte culture for flow cytometry. Nature 293:154, 1981.
  pubmed

• 16) Langlois, R. G., Yu, L. C. Gray, J. W. and Carrano, A. V.:Quantitative karyo-typing of human chromosomes by dual beam flow cytometry. Proc. Natl. Acad. Sci. U.S.A. 79:7876, 1982.

• 17) Davies, K. E., Young. B. D., Elles, R. G., Hill, M. E. and Williamson, R. (1981) :Cloning of a representative genomic library of the human X-chromosomeafter sorting by flow cytometry. Nature 293:374, 1981.
  pubmed

• 18) Lebo, R. V., Bastian, A. M.:Design and operation of a duel laser chromosomesorter. Cytometry 3:213, 1983. Cremer, C. and Gray, J. W.:Replication kinetics of chinese hamster chromosomes as revealed by bivariate flow karyotyping. Cytometry 3:282, 1983.

• 19) Horan, P. K. and Wheeless, L. L.:Quantitative single cell analysis and sorting. Science 198:149, 1977.
  pubmed

• 20) Krumlauf, R., Jeanpierre, M., Young, B. D.:Construction and chracterizationof genomic libraries from specific human chromosomes. Proc. Natl. Acad. Sci. U.S.A. 79:2971, 1982.
  pubmed

• 21) Kunkel, L. M., Tantravahi, U., Eisenhard, M. and Latt, S. A.:Regional localization on the human X of DNA segments cloned from flow sorted chromosomes. Nucleic Acid. Res. 10:1557, 1982.
  pubmed

• 22) Murray, J. M., Davies, K. E., Harper, P. S., Harper, P. S., Meredith, L, Mueller, C. R. and Williamson, R.:Linkage relationship of a cloned DNA sequence or the short arm of the X chromosome to Ducheme muscular dystrophy. Nature 300:69, 1982.
  pubmed

• 23) Disteche, C. M., Carrano, A. V., Ashworth, L. K., Burkhart-Schultz, K. and Latt, S. A.:Flow sorting of the mouse Cattanach X chromosome, T(X;7) 1Ct, in an active or inactive. state. Cytogenet. Cell. Genet. 29:189, 1981.
  pubmed

• 24) Disteche, C. M., Kunkel, L, M., Lojewski, A., Orkin, S. H., Eisenhard, M., Sahar E., Travis, B. and Latt, S. A.:Isolation of mouse X-chromosome specific DNA from X-enriched lambda phage library derived from Flow sorted chromosomes. Cytometrpt 2:282, 1982.
  pubmed

• 25) 貞包雄次郎, 渡辺武:Flow cytometry法によるヒト染色体のhigh resolution analysisおよびsorting. 医学のあゆみ 125:1006, 1983.

P.565 掲載の参考文献

• 1) Kavathas, P. and Herzenberg, L. A.:Proc. Natl. Acad. Sci. USA. 81:7688-7692, 1983.

• 2) 中内啓光:細胞工学 4:937-947, 1985.

• 3) Kavathas, P., Sukhatme, V. P., Herzenberg, L. A. and Parnes, J. R.:Proc Natl. Acad. Sci. USA. 81:7688-7692, 1984.
  pubmed

• 4) Littman, D. R., Thomas, Y., Maddon, P. J., Chess, L. and Axel, R.:Cell. 40:237, 1985.
  pubmed

• 5) Maddon, P. J., Littman, D. R., Godfrey, M., Maddon, D. E., Chess, L. and Axel, R.:Cell 42:93-104, 1985.
  pubmed

• 6) 中内啓光, 平田優子:医学の歩み別冊, 細胞遺伝子免疫 pp.163-169, 1987.

• 7) Hsu, C., Kavathas, P. and Herzenberg, L. A.:Natare 312:68, 1984.
  pubmed

• 8) Seed, B. and Aruffo, A.:Proc. Natl. Acad. Sci. USA. 84:3365-3369, 1987.
  pubmed

• 9) Kuhn, L., McClelland, A., and Ruddle, F. H.:Cell 37:95-103, 1984.
  pubmed

• 10) Radeke, M. J., Misko, T. P., Hsu, G., Herzenberg, L. A. and Shooter, E. M.:Nature 325:593-597, 1987.

• 11) Nolan, G. P., Fiering, S., Nicolas, J. F. and Herzenberg, L. A.:Proc. Natl. Acad. Sci. USA. (in Press).

• 12) Guinta, D. R. and Korn, L. J.:Mol. Cell. Biol. 6:2536-2542, 1986.
  pubmed

• 13) Gilbert, D. M.:Proc. Natl. Aced. Sci. USA. 83:2924-2928, 1986.

P.575 掲載の参考文献

• 1) Hoshino, T., et al:The distribution of nuclear DNA from human brain tumor cells:Flow cytometric studies. J. Neurosurg. 49:13, 1978.

• 2) Hoshino, T., et al:Clonogenicity of multiple populations of human glioma cells in vitro sorted by DNA content. Cancer 50:997, 1982.
  pubmed

• 3) Kobayashi, S., et al:Variable response to BCNU of human glioma cells sorted according to DNA content. J. Neuro-Oncol. 2:5, 1984.

• 4) 小林 秀・他:ヒトglioma細胞亜群の分離とその継代株の検討-コロニー形成能とBCNU感受性試験. 脳と神経 37:707, 1985.

• 5) Gray, J. W.:Flow cytometry and cell kineties:relation to cancer therapy. ln:Laerum et al(eds.), Flow Cytometry IV, Oslo:Universitetsforlaget, p.485, 1980.

• 6) Gray, J. W., et al:Rapid cell cycle analysis II. Phase duration and dispersion from computer analysis of RC curves. Cell Tissue Kinet. 16:457, 1983.
  pubmed

• 7) Pallavicini, M. G., et al:Quanititative analysis of the cytokinetic response of KHT tumors in vivo to 1-D-arabinofuranosylcytosine. Cancer Res. 42:3125, 1982.

• 8) Rice, G. C., et al:An ultra-pure in vitro synchrony method employing centrifugal elutriation and viable flow cytometric cell sortillg. Cytometry 5:289, 1984.
  pubmed

• 9) Freyer, J. P., et al:Coulter volume cell sorting to improve the precision of radiation survival assays. Radiat. Res. 97:608, 1984.
  pubmed

• 10) Freyer, J. P., et al:Viable sorting of intact multicellular spheroids by flowcytometry. Cpttometry 8:427, 1987.

• 11) Durand, R. E.:Oxygen enhancement ratio in V79 spheroids. Radiat. Res. 96:322, 1983.
  pubmed

• 12) Durand, R. E.:Use of a cell sorter for assays of cell clonogenicity. Cancer Res. 46:2775, 1986.
  pubmed

P.584 掲載の参考文献

• 1) Kreisberg, J. I., et al:Separation of proximal tubule cells from suspensions of rat kidney cells in density gradients of ficoll in tissue culture medium. Am. J. Pathol. 86:590, 1977.

• 2) Jones, D. P, et al:Use of isolated kidlley cells for study of drug metabolism. Biochem. Pharmacol. 28:929, 1979.
  pubmed

• 3) Heidrich, H. G., et al:Homogeneous cell populations from rabbit kidney cortex Proximal, distal tubule, and renin-active cell isolated by free-now electrophoresis. J. Cell Biol. 74:780, 1977.
  pubmed

• 4) Thimmappayya, B. et al:Preparation of kidney cell suspensions and respiration of kidney and liver cell suspensions. Exp.Cell Res. 63:333, 1970
  pubmed

• 5) Nagineni, C. N, et al:Isolation of cells from rabbit renal proximal tubules by using a hyperosmolar intracellular-like solution. Biochem. J. 223:353, 1984.
  pubmed

• 6) Berry, M. N., et al:High-yield preparation of isolated rat liver parenchymal cells. J. Cell Biol. 43:506, 1969.

• 7) Roser, B., et al:The distribution of intravenously injected Kupffer cells in the mouse. J. Reticuloendothelial. Soc. 5:455, 1968.

• 8) Mills, D. M., et al:Electron microscopic study of isolated Kupffer cells. Am. J. Pathol. 54:147, 1969.
  pubmed

• 9) Knok, D. L., et al:Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp.Cell Ret. 99:444, 1976.

• 10) Endou, H. et al:Use of a flow cytometer for the separarion of isolated kidney cells. Biochemistry of Kidney Function(Ed. by Morel F.), Elsevier North-Holland Biomedical Press pp.69, 1982.

• 11) Endou, H.:Cytochrome P450 monooxygenase system in the rabbit kidney;its intranephron localization and its induction. Jpn. J. Pharmacol. 33:423, 1983.
  pubmed

• 12) Kohler, G., et al:Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:496, 1975.

• 13)「Immunochemistry in Practice」 Eds. by Johnstone, A. Blackwell Sciectific Publications. 1982.

• 14) Koseki, C., et al:Intercalated cells of rabbit kidney:Their isolation by monoclonal antibody and characterization. Kidney Int. 33:in press, 1988.

• 15) 北条一夫・他:Cell sorter(Flow cytometer) を利用したKupffer細胞の単離とその特性. Acta Hepat. Jpn. 23:864, 1982.

• 16) Gumucio, J. J., et al:Transport of fluorescent compounds into hepatocytes and the resultant zonal labeling of the hepatic acinus in the rat. Gastroenterology 30:639, 1981.

• 17) 筋野甫・他:単離ラット肝実質細胞の亜分画に関する研究. Acta Hepat. Jpn. 25:1433, 1984.

• 18) 遠藤仁・他:肝小葉中心部並びに周辺部細胞の分取とP450局在の特異性. 第68回日本薬理学会関東部会講演要旨 p.33, 1983.

P.605 掲載の参考文献

• 1) Sandritter, W., et al:Zur Krebs Diagnostik an Vaginalen Zellausstrichen mittels Cytophotometry Messungen. Arch. Gynnnecol. 19:293, 1960.

• 2) 西谷巌・他:子宮癌細胞の計量診断と蛍光顕微分光測光法. 産婦治療 33:98, 1976.

• 3) 下斗米啓介・他:Information zur Kerntechnik, Nrl, 18, 1975.

• 4) 井筒俊彦:子宮頸癌検診の再編成. 第31回日産婦学会北日本連合地方部会特別講演要旨 40, 1983.

• 5) Melamed, M. R., et al:Flow cytometry and sorting, 1st Ed. 351, John Wiley&Sohns, New York, 1979.

• 6) 西谷巌:細胞群の選別・解析とその臨床応用. 臨床婦産 34:169, 1980.

• 7) 西谷巌・他:細胞機能解析コンピューターの臨床における工夫と実践. 臨床婦産 36:316, 1982.

• 8) Soost, H. J., et al:Comparison of Papanicolaou staining and Feulgen stainingfor automated presceening. J. Analytical & Quantitative Cytol. 5:61, 1983.

• 9) Fowlkes, B. J, et al:Flow microfluorometric system for screening gynecologiccytology specimens using propidium iodide-fluorescein isothiocyanate. J. Histochem. Cytochem. 24:332, 1976.

• 10) Iwao Nishiya, Yoshiaki Ishizaki, Keisuke Shimotomai, Ichiro Sawamura, Kohichi Tamura and Masayoshi Akama:Microspectrophotometric screening system withmulti-fiber scanning, practically feasible for detection of premaligmant and malignant lesions of the cervix. Proc. Japan Acad. 56:73, 1980.

P.616 掲載の参考文献

• 1) Barlogie, B., et al:Cellular DNA content as a marker of neoplasia in man. Jon. Medicine 69:195, 1980.

• 2) Crissman, H. A., et al:Rapid simultaneous measurement of DNA, protein andcell volumes in single cells from large mammalian cell populations. J. Cell Biol. 59:766, 1973.

• 3) Crissman, H. A., et al:Rapid staining methods for analysis of deoxyribonucleicacid and protein in mammalian cells. J. Histochem. and Cytochem. 24:64, 1976.

• 4) 山田憲夫:原発性肺癌のDNA-RNAを指標とした悪性度評価の試み -特にFlow Cytometryを応用して-. J. Jpn. Soc. Cancer Ther. 22:2252, 1987.

• 5) Bunn, P. A., et al:Diagnostic alld biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res. 43:5026, 1983.

• 6) Teodori, L., et al:Non-small cell lung carcinoma:Tumor characterizationon the basis of flow cytometrically determined cellular heterogeneity. Cytology 4:174, 1983.
  pubmed

P.634 掲載の参考文献

• 1) 野田起一郎:子宮頸部上皮の癌化防止に関する研究. 日産婦誌 27(3) :735, 1975.

• 2) 岸上義彦・他:自動スクリーニングに通した膣スミアの作成法, 特に好中球の除去について. 日臨細胞誌 20(3) :523-531, 1981.

• 3) 阪口耀子・他:Flow-cytometryのための組織細胞分散法の確立. 日臨細胞誌 22(2) :228-234, 1983.

• 4) K. Goerttler., et al:Highlighting of progress by Research Groups in cytology Automation:The Automation of Cancer Cytology and Cell Image Analysis (Editors, Norman J. Pressman and George L. Wied), 13-18, Tutorials of Cytology Chicago, Illinois, 1979.

• 5) M. Stoehr., et al:Dual Laser Flow Analysis and Sorting of Cells Includingthe Uterine Cerix:The Automation of Cancer Cytology and Cell Image Analysis(Editors, Norman J. Pressman and George L. Wied) ;75-80, Tutorials of Cytology Chicago, Illinois, 1979.

• 6) R. H. Jensen., et al:Multiparameter Flow Cytometry Applied Toward Diagnosis of Cervical Squamous cell Carcinoma:The Automation of Canaer Cytology and Cell Image Analysis (Editors, Norman J. Pressman and George L. Wied) ;95-102, Tutorials of Cytology Chicago, Illinois, 1979.

P.652 掲載の参考文献

• 1) Mullaney, P. F. et al:The Small Angle Light Scattering of Biological Cells. Biophysical Jounal 10:764, 1970.

• 2) Salzman, G. C., et al:Cell Classification by Laser Light Scattering:Identification and Separation of unstained Leukocytes. Acta Cytologica 19(4) :374, 1975.

• 3) Van den Engh, G. J.:Concentration of Haemopoietic Cells using a Light Activated Cell Sorter. Blood Cells 6(4) :609, 1980.

• 4) 福井谷祐一・他:フローサイトメトリーの癌臨床への応用. 癌と化学療法 9(7) :1204, 1982.

• 5) Meyer, R. A., et al:Light Scattering from nucleated biological cell. Biophys. J. 15:191, 1975,
  pubmed

• 6) Otten, G. R.:Two Color Light Scattering Identifis physical Differences between Lymphocyts Subpopulations. Cytometry 3(3) :182, 1982,
  pubmed

• 7) Watt S. M., et al:Isolation of Mouse Bone Marrow Neutrophils by Light Scatter and Autofluorescence. J. Histochem. Cytochem. 28(9) :934, 1980.
  pubmed

• 8) Grogan, W. M., et al :Application of Light Scatter to Separation of Stem Cells. Blood 6:625, 1980.
  pubmed

• 9) 福井谷祐一・他:Light Scatteringの造血器悪性腫瘍診断への応用. 最新医学 40(1):92, 1985.
  Medical*Online

• 10) Martin, A., et al.:Charactarization and Sorting of Mouse Cytotoxic Macrophages by Their Light Scattering properties. Cytometry 4:250, 1983.

• 11) Porath-Furedi A., :The Mutual Effect of Hydrogen Ion Concentration and Osmotic Pressure on the Shape of Human Erythrocyte as Determined by Light Scattering and by Electronic Cell Volume Measurment. Cytometry 4:263, 1983.
  pubmed

• 12) Benson, M. C., :The Application of Perpendicular and Forward Light Scatter to Assess Nuclear and Cellular Morphology. Cytometry 5:515, 1984.
  pubmed

• 13) Rigler, R., et al.:Rotation and Translational Swimming of Human Spermatozoa. A Dynamic Laser Light Scattering Study. Cytometry 5:327, 1984.
  pubmed

• 14) Paul, L. McNeil., et al.:Light-Scattering changes During Chemotactic Stimulation of Human Neutrophils:Kinetics Followed by Flow Cytometry. Cytometry 6:7, 1985.

• 15) Terestappen, L. W. M. M., et al:Physical Discrimination Between Human T-Lymphocyt Subpopulations by Means of Light Scattering, Revealing two populations of T8-positive Cells. Cytometry 7(2) :178, 1986.

• 16) Van Bockstaele, et al:Flow Cytometric Analysis of Hairly Cell Leukemia Using Right-Angle Light Scatter. Cytometry 7(2) :217, 1986.

• 17) Grooth, B. G. de. et al:White Blood Cell Differentiation Using Depolarized Orthogonal Light Scattering. Cpttometry(Supple) 35:1987.

• 18) MacDonald, H. R., et al:Light Scatter Analysis and Sorting of cells Activatedin Mixed Leukocyte Culture. Cytometry 3:55, 1982.

VIII. データ解析法

P.666 掲載の参考文献

• 1) Gray, J. W, Dean, P. N. and Mendelsohn, M. I., :Quantitative cell-cycle analysis, in Flow Cytometry and Cell Sorting(eds. Melamed. M. R., Mullaney, P. F. and Mendelsohn, M. I.) John Wiley and Sons. pp.383, 1979.

• 2) Barlogie, B. Drewinko, D. A., et al:Pulse cytophotometric analysis of synchronized cells in vitro. Cancer Res. 36:1176, 1976.

• 3) Takahashi, M.:Amultidhannel method for the analysis of DNA contentdistribution using flow cytometric data. Comput. Biomed. Res 14:506, 1981.

• 4) Watson, J. W.:The application of age distribution theory in the analysis of cytofluorimetric DNA histogram data, Cell Tssue Kinet. 10:157, 1977.

• 5) Kim, M. and Perry, S.:Mathematical model for determining cell DNA synthesis rate and age distribution utilizing flow microfluorometry. J. Theoret. Biol. 68:27, 1977.

• 6) Woo, K. B.:The discrete-time kinetic model analysis of DNA distributions inexperimental tumor cells. Cell Tissue Kinet. 12:111, 1979.

• 7) Kraemer, P. M., Petersen, D. F. and Van Dilla, M. A.:DNA constancy inheteroploidy and the stem line theory of tumors, Science 174:714, 1971.
  pubmed

• 8) Kraemer, P. M., Deaven, L. L, Crissman, H. A. and Van Dilla, M. A.:DNAconstancy despite variability in chromosome number. Adv. Cell Molec. Biol. 2:47, 1972.

• 9) Fried, J.:Method for the quantitative evaluation of data from flow micro-Huorometry. Comput. Biomed. Res. 9:263, 1976.

• 10) Dean, P. N. and Jett, J. H.:Mathematical analysis of DNA distributionsderived from flow microfluorometry. J. Cell Biol. 60:523, 1974.
  pubmed

• 11) Van der Linden, P. M.:An iterative method of analysis for DNA histograms. in Flow Cytometry IV, (eds. Laerum, O. D., Lindmo, T. and Thorud. E.) Universitetforlaget, pp.133, 1980.

• 12) Takahashi, M.:DNA histogram analysis of exponentially growing and perturbed cell populations. in Biomathematics and Cell Kinetics(ed. Rotenberg, M.) Elsevier/North-Holland, pp.211, 1981.

• 13) Dean. P. N., Gray, J. W. and Dolbeare, F. A.:The analysis and interpretationof DNA distributions measured by flow cytometry. Cptometry 3:188, 1982.

P.675 掲載の参考文献

• 1) 高瀬浩造:Flow cytometryを用いた蛍光標識モノクローナル抗体染色陽性細胞率の算定方法. 最新医学 40:45, 1985.

• 2) Takase, K., et al:Quality control approach to the lymphocyte immunophentoyping. Proceedings of the 6th International Symposium on Quality Control-Osaka. Excerpta Medica, Tokyo. (in press)

• 3) 高瀬浩造・他:フローサイトメトリーによる表面形質分析における陽性率算出法についての検討 -とくにDEST 3のアルゴリズムについて-. 臨床免疫 17:408, 1985.

• 4) 高瀬浩造・他:モノクローナル抗体による細胞表面抗原検出における非特異反応の成因とその除去に関する研究. 日本臨床免疫学会会誌 8:184, 1985.

• 5) Nelder, J. A., et al:Asimplex method for function minimization. Computer J. 7:30 8, 1965.

• 6) Takase, K., et al:Cytoplasmic CD3 antigen and T cell receptor gene rearrangement in surface CD3 negative T cell malignancy. Jpn. J. Clin. Oncol. 17:237, 1987.

• 7) 野々山恵章:細胞質内μ鎖の検出法. 臨床免疫 19 〔Suppl.12〕:44, 1987.

P.687 掲載の参考文献

• 1) 久下 栄:Two-Color Flow-Cytometryの現状とその問題点. 最新医学 39(2):302, 1984.
  Medical*Online

• 2) Oi, V. T, Glazzer, A. N., et al.:Fluorescent Phycobiliprotein Conjugates for analyses of cells and molecules. J. Cell Biol. 93:981-986, 1982.

• 3) Loken, M. R. et al.:Three-Color Immunofluorescence Analysis of Leu-Antigens on Human Peripheral Blood Using Two Lasers on a Fluorescence-Actirated Cell Sorter. Cytometry 5(2) :151-158, 1984.

• 4) Parks, D. R. Hardy, R. R. Herzenberg, L. A.:Three-Color Immunofluorescence Analysis of Mouse B-Lymphocyte Subpopulations. Cytometry 5(2) :159-168, 1984.
  pubmed

• 5) Steinkamp, J. A. et al:A Modular Detector for Flow Cytometric Multicolor Fluorescence Measurements. Cpttometry 8(4) :353-365, 1987.
  pubmed

IX. その他

P.706 掲載の参考文献

• 1) Van Furth, R.:Mononuclear Phagocytes, Functional Aspects I (ed. by van Furth, R), Martinus Hijnoff 1, 1980,

• 2) 酒井 寛・他:Flow cytometryによる好中球貧食能試験の測定条件について. 衛生検査 35(10):1421-1424, 1986.

• 3) 合地研吾・他:臨床血液. 抄録:1985.

• 4) 多賀千之・他:フローサイトメトリーを用いた微量全血法による好中球機能検査. 臨床免疫 17(5):490-485, 1985.

• 5) 岩瀬正泰:血漿ファイブロネクチンの好中球機能への影響. 炎症7(1):73-77, 1987.

• 6) 杉之下俊彦:単球貧食能測定法-フローサイトメトリー手技と実際- (太田和雄他編). 蟹書房 pp.498-505, 1984.

• 7) 岩崎秀生・他:蛍光ビーズを用いた末梢血Leu-M3陽性細胞の貧食能の測定. FCM-cell Biology研究会:1987.

• 8) 山田充宏・他:フローサイトメトリを用いた肺胞マクロファージ貧食能測定法の特長と問題点. 日本臨床免疫学会抄録 p.336. 1987.

• 9) 鈴木是光・他:FCMによる白血球機能検査-貧食能検査を中心として-. 臨床病理 33(12):1338-1347, 1985.

• 10) Owen, C. Blair., et al:Differentiation of HL-60 Promyelocytic Leukemia Cells:Simultaneous Determination of Phagocytic Activity and Cell Cycle Distribution by Flow Cytometry. Cytometry 7:171-177, 1986.

• 11) Bassoe, C. F., et al:Simultaneous Measurment of Phagocytosis and Phagosomal pH by Flow Cytometry:Role of Polymorphonuclear Neutrophilic Leucocyte Granules in Phagosome Acidification. Cytometry 4:254-262, 1983.
  pubmed

• 12) John, A. Steinkanp., et al:Phagocytosis:Flow Cytometry Quantitation. with Fluoresent Microspheres. Science 215(1) :64-66, 1982.

• 13) 渡部一郎・他:Flow cytometryを用いた全血法による貧食能の検討. 日本臨床免疫学会抄録 p.282:1986.

P.713 掲載の参考文献

• 1) Krishan, A., et al:Effects of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells. Cancer Res. 38:3656-3662, 1978.
  pubmed

• 2) Krishan, A. and Ganapathi, R.:Laser flow cytometry and cancer chemotherapy:detection of intracellular anthracyline by flow cytometry. J. Histochem Cpttochem. 27:1655-1656, 1979.

• 3) Krishan, A. and Ganapathi, R.:Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Cancer Res. 40:3885-3900, 1980.

• 4) Nooter, K., et al:Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells. Cancer Res. 43:5126-5130, 1983.
  pubmed

• 5) Krishan, A., et al:Flow cytometric studies on modulation of cellular adriamycin retention by phenothiazines. Cancer Res. 45:1046-1051, 1985.
  pubmed

• 6) Skovsgaard, T.:Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumor cells. Biochm Pharmacol. 26:215-222, 1977.

• 7) 佐々木功典・他:Flow cytometryによるadriamycin取り込み排出の解析. 日癌治誌 19:1028-1031, 1984.

• 8) Tapiero, H, et. al:Comparative uptake of adriamycin and daunomycin in sensitive and resistant friend leukemia cells measured by flow cytometry. Cytometry 2:298-302, 1982.

• 9) 長岡 栄・他:各種細胞におけるadriamycinの取り込み, 排泄及び感受性の解析. 日癌治誌 21:991-997, 1986.

• 10) Tokita, N., et al:Cell cycle-dependent adriamycin uptake in chinese hamster cells. Eur. J. Clin. Oncol. 21:243-247, 1985.

• 11) 佐々木功典・他:Flow cytometryによる3T3細胞内アドリアマイシンの測定. 日癌治誌 20:66-70, 1985.

• 12) Tsuruo, T., et al:Circumvention of VCR and ADR resistance in vitro and in vivo by calcium influx blockers. Cancer Res. 43:2905-2910, 1983.

• 13) 川崎 祥二・他:Adriamycinの細胞内取り込みへのhyperthermiaの影響. 日医放射線会誌 44:727-731, 1984.

• 14) 長岡 栄・他:アルカロイド(セファランチン)によるアドリアマイシンの細胞内取り込みおよび排泄の修飾. 医学のあゆみ 133:260-261, 1985.

• 15) Nagaoka, S., et al:Intracellular uptake, retention and cytotoxic effect of adriamycin combined with hyperthermia in vitro. Gann 77:205-211, 1986.
  pubmed

• 16) Nagaoka, S., et al:Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitro. Eur. J. Clin Oncol. 23:1297-1302, 1987.

• 17) 佐々木功典・他:細胞のアドリアマイシン取り込みに及ぼすカルシウム拮抗薬の影響. 癌と化学療法 12:966-968, 1985.
  Medical*Online

• 18) Krishan, A., et al:Flow cytometric monitoring of cellular anthracyclineaccumulation in murine leukemic cells. Cancer Res. 46:1768-1773, 1986.

• 19) Willingham, M. C., et al:Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and-sensitive KB cells:effects of verapamil and otherdrugs. Cancer Res. 46:5941-5946, 1986.

P.724 掲載の参考文献

• 1) 西谷 巌, 善積 昇, 平間隆之:悪性腫瘍の化学療法とダイナミックテスト. 臨床婦産 35:731, 1981.

• 2) Sevin, B. U., Ramos, R. and Averette, E.:The potential use of cell kineticsin the treatment of ovarian malignancies. Cancer Campaign. Grundmann E. (ed.) Vol 7, Carcinoma ovary, Gustav Fischer Verlag, Stuttgart, New York, 1983.

• 3) Crissman, H. A. and Tobey, R. T.:Cell cycle analysis in 20 minutes. Science. 184:1297, 1974.

• 4) 星野孝夫:試料作成法;染色法, Hoechst 33342によるDNAの生体染色, フローサイトメトリー -手技と実際-102, 蟹書房(初版) 1984.

• 5) Kikuchi, Y., Miyauchi, M., Kizawa, I., Oomori, K., and Kato, K.:Establishment of a Cisplatinum-resistant human ovarian cancer cell line. J. Natl. Cancer Inst, 19.

• 6) 西谷巌, 利部輝雄, 井筒俊彦, 善積昇, 臼木豊:子宮頸癌に対するCisplatin(CDDP) 動注効果の基礎的・臨床的検討. 産婦の実際 34:537, 1985.

• 7) Wennenberg, J., Alm, P., Biorklund. A., Killander, D., Langstrom. E. and Trope, C.:Cell cycle pertur 6 bations in heterotrans planted squamous cellcarcinoma of the head and necks after mitomycin and cisplatin treatment. Int. J. Cancer 33:213, 1984.

• 8) 稲葉実:癌細胞の薬剤耐性に関する一般的考察. 癌と化学療法 9:165, 1982.
  Medical*Online

P.741 掲載の参考文献

• 1) Bates, S. E, et al:Use of serum tumor markers in cancer diagnosis. Semin. Oncol. 17 :102, 1987.

• 2) 池内駿之・他:食道癌のEGFレセプターおよびTransferrinレセプター発現 -sm 表在癌を中心として-. Oncologia 20:117, 1987.

• 3) 関口守正・他:KATO III(JTC-28)株細胞. 組織培養 9:117, 1983.

• 4) Toni, U., et al:Tumor and lymphoid cell lines from a patient with carcionma of the colon for a cytotoxicity model. Cancer Res. 38:1345, 1978.

• 5) Giard, D. J., et al:In vitro cultivation of human tumors:establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51:1417, 1973.
  pubmed

• 6) Chatelier, R. C., et al:Binding of fluoresceinated epidermal growthfactor to A431 cell sub-populations studies using a model-independent analysis offlow cyto-metric fluorescence data. The EMBO Journal 5:(6) 1181-1186, 1986.

• 7) Sakai, P. T., et al:Discrimination of viable and non-viable cells using prop-idium iodide in two color immunofluorescence. Cytometry 8:413-420, 1987.

• 8) Gold, P., et al:Demonstration of tumor specific antigens in human colonic carcinoma by immunologic tolerance and absorption techniques. J. Exp.Meb., 121 :439, 1965

• 9) 松岡雄治:CEAおよび関連抗原の新しい腫瘍マーカーとしての可能性. 癌と化学療法 10:1754, 1983.
  Medical*Online

• 10) Murao, R., et al:Definition by monoclonal antibodies of a repertoire of epitopes on carcino embryonic antigen differentially expressed in humancolon carcinomas versus normal adult tlssues. Cancer Res. 45:5769, 1985.

• 11) 畑田率達・他:Monoclonal抗体によるCEAの免疫組織学的研究. 最新医学 38 :401, 1983.
  Medical*Online

• 12) Kitagawa, H., et al:Characterization of carcino embryonic antigen-specific monoclonal antibodies and specific carcinoembryonic antigen assay in seraof patients. Jpn. J. Cancer Res. (Gann) 77:922, 1986.

• 13) Koprowski, H., et al:Colorectal carcinoma antigens detected by hybridomaantibodies. Somatic Cell Genctics. 5 :957, 1979.
  pubmed

• 14) Magnani, J., et al:A monoclonal antibody-defiened antigen associated with gastroilltestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose II. J. Bio. Chem. 257:14365, 1982.

• 15) Kawamoto, T., et al:Growth stimulation of A431 cells by epidermal growthfactor:Identification high affinity receptors for epidermal growth facter by an anti-receptor monoclonal antibody. Pro. Nati. Acad. Sci. U.S.A. . . 80:1337, 1983.

• 16) Greaves, M., et al:Expression of the OKT monoclonal antibody definedantigenic determination of malignancy. Int. J. Immzanopharmac. 3:283, 1981.

• 17) Ensley, J. F., et al:Solid tumor preperation for flow cytometry using a standard murine model. Cytometry 8:479, 1987.

• 18) Nagata, M., et al:Action of the bacterial neutral protease, on cultured cells and its application to fluid suspension culture with a review on biochemical application of this protease. Jph. J., Exp. Med 56:297, 1986.

• 19) Ikemoto, S., et al:Transformation of blood group antigens and release of amino acids induced by Dispase treatment. Jpn. J. Legal Med 3:1, 1984.

• 20) Chinkers, M., et al:Characterization of structural domains the human epidermal growth factor receptor obtained by partial proteolysis. J. Biol. Chem. 259:11534, 1984.
  pubmed

• 21) Waymouth, E.:To disaggregate or not to disaggregate. Injury and celldisaggregation, transient or permanent? In Vitro 10:97, 174.
  pubmed

• 22) Schwartz, R., et al:Assay for the determination of human carcinoma cellsin circulation blood. J. Cancer Res, Clin-Oncol. 109:122, 1985.

• 23) Frans, C. S., et al:Flow-cytometric analysis of mixed cell populations using intermediate filament antibodies. Exp.Cell Pes. 153:249, 1984.

X. 新しいFCMの装置

P.755 掲載の参考文献

• 1) Van Dilla, M. A., et al:Human chromosome-specific DNA libraries:construction and availability, Bio/Technology, vol. 4, 537, 1986.

• 2) 橋本雄之:液色体のソーティングと遺伝子ライブラリー. 蛋白質 核酸 酵素 31:(13) 1451, 1986.

• 3) Botstein, D., et al:Construction of a genetic linkage map in man using restriction fragment length polymorphisms:Am. J. Hum. Genet. 32:314, 1980.
  pubmed

• 4) 高井新一郎・他:家系分析にいる遺伝子マッピングの革命. 蛋白質 核酸 酵素 31:13, 1340, 1986.

• 5) 中村祐輔:リンケージ解析と高多型性DNAマーカー. 蛋白質 核酸 酵素 31(13) :1354, 1986.

• 6) 青山伸郎・他:疾病の遺伝子解析と染色体マッピング. 病理と臨床 5(2) :165, 1987.

• 7) 畑中正一:遺伝子診断と病理診断. 病理と臨床 5(2) :173, 1987.

• 8) 野口義夫・他:最近のレーザーフローサイトメータ. レーザー研究 15(8) :647, 1987.

• 9) Dean, P. N., et al:High resolution dual laser flow cytometry., J. Histochem. Cytochem. 26:622, 1978.
  pubmed

• 10) Peters, D., et al:The LLNL high-speed sorter:design features, operational characteristics, and biological utility. Cytometrpt 6:290, 1986.

• 11) Lebo, R. V., et al:Design and application of a versatile triple-laser cell andchromosome sorter Cytometry 8:71, 1987.

• 12) Lebo, R. V., et al:High-resolution chromosome sorting and DNA spot-blotanalysis assign McArdles syndrome to chromosome 11. Science 225:57, 6 July 1984.

• 13) 岸 裕幸・他:リンパ球の受容体, 受容体と情報伝達, 183, (現代化学・増刊4, 宇井理生編, 東京化学同人, 東京, 1985.

• 14) Mullikin, J., et al:Fringe-scan flow cytometry Technical Report of LLNL, 1987.

• 15) Born, M. and Wolf, E.:Principles of Optics, Chapter 8, Pergamon Press, Oxford, 1975.

• 16) Norgren, R. M., et al:U. S. Patent 4, 596, 036, 1896.

• 17) Norgren, R. M., et al:Restoration of profiles from slit-scan flow cytometry. IEEE Trans. BME-29, 101, 1982.

• 18) Lucas, J. N., et al:Centromeric index measurement by slit-scan flow cytometry. Cytometry 4:109, 1983.
  pubmed

• 19) Lucas, J. N., et al:Centromeric index versus DNA content flow karyotypes ofhuman chromosomes measured by means od slit-scan flow cytometry. Cytometry 8:273, 1987.

• 20) 野口義夫・他:ピコ秒パルスレーザを用いた新しいフロー・サイトメータ. 電子通信学会全国大会予稿集, 7-249, 1985.

• 21) Wick, G., et al:U. S. Patent 4, 444:, 317, 1984.

XI. 各種機器

P.775 掲載の参考文献

• 1) Mullaney, P. F., et al:Pulse height light-scatter distributions using flow systems instrumentation. J. Histchem. Cytochem. 24:298, 1976.
  pubmed

• 2) Salzman, G. C., et al:Light-scattering approaches to cell characterization. pp.105 in flow cytometry and rorting, John Wiley and Sons, 1979.

• 3) Fuwyler, M. J.:Electronic separation of biological cells by volume, Science 150:910, 1965.

• 4) Hulett, H. R., et al:Cell sorting:Automated separation of mammalian cells as a function of intracellular fluorescence. Science 166:747, 1969.

• 5) Herzenberg, L. A., et al:Fluorescence activated cell sorting. Scientific American, pp.108, March 1976.

• 6) Kamentsky, L. A., et al:Spectrophotometer:New instrument for ultrarapid cell analysis, Science 150:630, 1965.
  pubmed

• 7) Kamentsky, L. A., et al:Spectrophotometric cell sorter. Science 156:1364, 1967.
  pubmed

P.790 掲載の参考文献

• 1) Baisch, H., Gohde, W., Linden, W. A.:Analysis of PCP-data to determinethe fraction of cells in the various phases of cell cycle. Rad. and Environm. Biohys. 12:31-39, 1975.

• 2) Dann, O. G., Bergen, E., Demant, E., Demallt, E., Volz, G, :Trypanocide Diamidine des2-Phenylbenzofurans, 2-Phenyl-indens and 2-Phenylindols. Liebigs Ann. Chem. 749:68-89, 1971.

• 3) Gohde, W., Dittrich, W.:Simultane Impulsfluorometrie des DNS-und Protelngehaltes von Tumorzellen. Z. Anal. Chemie. 252:328-331, 1970.

• 4) Gohde, W., Dittrich, W.:Impulsfluorometrie-ein neuartiges Durchflu Bverfahren zur ultraschnellen Mengenbestimmung von Zellinhaltsstoffen. Vortag:XIII. Tagung der Gesellschaft for Histochemie, Graz, 1969. Acta Histochemica 10 (Suppl.) :429-437, 1971.

• 5) Gohde, W., Schumann, J., Buchner, Th., Barlogie, B.:Influence of irradiation and cytostatic drugs on proliferation patterns of tumor cells. In:Pulse Cytophotometry, ed. by C. Haanen et al. 1975, European Press Medicon, pp.138-152.

• 6) Gohde, W., Schumann, J., Zante, J.:The useof DAPI in pulse cytophotometry. Pulse Cytophotometry 1978, pp.229-232.

• 7) Hacker, U., Schumann, J., Gohde W.:Mammalian spermatogenesis as a newsystem for biologic dosimetry of lonizing lrradiation. Acta Radiol. Oncology 21:349-351, 1982.

• 8) Limmacher:personliche Mittellung. Otto, F. J., Oldiges, H, Gohde, W., Jain, V. K.:Flow cytometric measurement of nuclear DNA content variationsas a potential in vivo mutagenicity test. Cytometry 2:189-191, 1981.

• 9) Rotman, B., Papermaster, B. W.:Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc. Natl. Acad. Sci. USA. 55:135, 1966.

• 10) Thom, R.:Modern concepts in hematology, Academic Press, N. Y.:1972.

• 11) Tobey, R. A., Oka, M. S., Crissman, H. A.:Analysis of chemotherapeutic agents on cell growth kinetics In cultured cells. In:Flow cytometry and sorting, ed. by Melamed, M. R., et al. 1979, John Wiley & Sons, pp.573-582.

• 12) Vandilla, W. A., Trujillo, T. T., Mullaney, P. F., Coulter, J. R.:Cell microfluorometry:Amethod for rapid fluorescence measurements. Science 163:1213-1214, 1969.